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Abstract
A major focus of my work has been to understand the mechanism/s of sepsis
development during respiratory bacterial infections with the goal of identifying novel
alarmins/alarmin receptors. Specifically, I have analyzed the role of C-type lectins as
novel alarmin/alarmin receptors likely involved in the development of sepsis resulting
from acute pulmonary infection with Gram negative bacteria Francisella novicida and
Klebsiella pneumonia (Kpn). In that regard, the first project was built upon a previous
observation, made by Dr. Sharma, that two soluble lectins galectin-3 and -9 were
upregulated and released in extracellular milieu in lungs of mice upon pulmonary
infection with Francisella novicida (Fn). As alarmins are endogenous molecules released
from dead/dying cells under pathological conditions, we wanted to examine if galectin-3
and -9 act as alarmins to exacerbate the inflammatory response during Fn infection. I
was brought in as a co-author on the studies with galectin-3 where I examined the effect
of this lectin on myeloid cell activation. My work showed that pre-treatment of primary
neutrophils and macrophages with recombinant galectin-3 augmented Fn-induced
activation of these cells in terms of increased reactive oxygen species and inflammatory
cytokine production. Together with improved lung architecture, reduced cell death and
improved survival of galectin-3-/- mice in comparison with the wild-type mice , these
findings suggested

that galectin-3 functions as an alarmin by augmenting the
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inflammatory response in sepsis development during pulmonary Fn [1]. Similar studies
with galectin-9 showed that galectin-9 also acts an alarmin during Fn infection-induced
sepsis [2]. In the second project, we specifically examined the function of Clec4d, a
mammalian C-type lectin receptors (CLRs) as possible alarmin receptor in the
development of Gram-negative pneumonic sepsis caused by KPn. In our initial analysis,
we found that this CLR was upregulated in the lungs of mice infected with KPn. In our
follow up studies we observed a protective role of this receptor in pneumonic sepsis. In
my paper as the first author we showed that Clec4d-/- mice have an increased
susceptibility to KPn infection, increased bacterial burden in systemic organs as well as
blood, increased lung pathology as evident by increased accumulation of Ly6G+/CD11b+
neutrophils and hyperinflammatory response [3]. While we observed no defect in
bacterial phagocytosis in the absence of Clec4d, we found a possible role of Clec4d in
turnover of neutrophils by efferocytosis. In another paper that I co-authored as second
author, we showed a protective role of another CLR Mincle. In this study I was primarily
involved in demonstrating the increased susceptibility of Mincle-/- mice to KPn
pneumonia by reduced survival, increased bacterial burden and hyperinflammatory
response [4]. On the basis of these findings, further studies are currently ongoing in
Sharma lab to characterize the specific functions of Clec4d and Clec4e as part of separate
projects.
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INTRODUCTION
Sepsis and Pneumonia: Healthcare burden and treatment
A precise estimation of the number of cases in the US has been difficult partly due to the
heterogeneity of the disease and the methodology used. Regardless of the range of
estimated cases (256,000-750,000 annually in the US) and the associated mortality
(28.6%-37.7%) reported [5-8], one thing is clear: despite decades of dedicated research
efforts, occurrence of sepsis and septic shock has increased significantly over the past
two decades. An accurate estimation of the disease incidence and mortality is critical for
proper distribution of health care resources and a consistent definition of this complex
disorder would help identify sepsis cases uniformly. Hence the American College of
Chest Physicians and Society for Critical Care Medicine defined sepsis, severe sepsis,
and septic shock as a disease complex with varying degrees of organs dysfunction
resulting from a host response to systemic infection [9-11]. As a result of this uniform
definition, sepsis has been recognized as a major US healthcare burden and according to
Centers for Disease Control and Prevention, it is the 11th leading cause of deaths in the
US, and the leading cause of non-coronary deaths in ICU patients [12,13]. Moreover,
severe sepsis, defined as sepsis associated with organ dysfunction and hypoperfusion/
hypotension with extremely high ICU admission rate has been estimated to cost the U.S.
healthcare system $24.3 billion in 2007 [14]. A mortality rate of approximately 50% is
1

associated with septic shock, which is highly unacceptable [5]. Individuals at the highest
risk of developing sepsis or severe sepsis include older adults of over 65 years of age,
patients with chronic disease conditions such as cancer, diabetes, chronic obstructive
pulmonary disease, chronic liver or kidney diseases and individuals with abnormal
immune response to infections [15,16].
Respiratory tract infections and pneumonias are the most common cause of sepsis
(accounting for almost 50% of all sources of infections) and are associated with highest
mortality rates [15,17] . Despite a recent increase in the numbers of Gram positive
bacterial infection cases, Gram negative infections remain the cause of the highest
mortality [18,19]. Interestingly, a recent study found that a lung infection was more
commonly the primary cause of sepsis in patients with a negative culture than in patients
with a positive culture [20]. This may indicate the critical need for biomarkers and
improved methodologies for detection and prognosis of pneumonia. Gram negative
bacteria belonging to Enterobacteriaceae family (e.g. E.coli and Klebsiella species) are
the most common causes of sepsis [21,22].
Despite continuous and dedicated research on sepsis (a total of 139,200 Pubmed entries
with the keyword “sepsis”; first article published in 1886), and hundreds of clinical trials,
we are still ways from finding a treatment for this deadly disorder. This may partly be
due to the complexity of this disease and the fact that immune regulatory processes
controlling sepsis are not completely understood. Due to the overactivation of proinflammatory cascades occurring during a microbial infection, the initial attempts to treat
sepsis centered around dampening or blockage of inflammatory cytokines (reviewed in
[23]). Due to its central position in auto-and paracrine loops of numerous inflammatory
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mediators, tumor necrosis-α (TNF-α) has been the target of most anti-cytokine therapies
which have failed in clinical trials [24,25]. We have come a long way since the
recognition of “cytokine storm or hypercytokinemia”; a condition of co-existence of both
pro- and anti-inflammatory cytokines. Moreover, with strong evidence of the complexity
of sepsis, characterized by a cross-talk between multiple biological systems (reviewed in
[26]), it is now clear that targeting a single biomolecule is highly unlikely to provide cure
for heterogeneous sepsis patient population. For a number of years, recombinant
activated protein C was the only FDA approved drug for sepsis treatment that targeted
disseminated intravascular coagulation (DIC)”, a major complication of sepsis. However,
in October 2011, this drug (Xigris) was withdrawn from market following the much
anticipated results of the clinical trial (PROWESS-SHOCK) where it failed to show any
survival benefit for severe sepsis and septic shock patients [27]. This underscores the
need for a better understanding of immune dysfunction that will likely identify novel
targets for successful treatment of this disorder.

Inflammatory Mechanisms in sepsis: Role of alarmins
Sepsis is mainly characterized by an imbalanced, hyper-inflammatory response to an
infection. As for any pathogenic insult, innate immune components play pivotal role in
initiating the pro-inflammatory response required to combat infection. The key players in
this process are host Pattern Recognition Receptors (PRRs) and pathogen-associated
molecular patterns (PAMPs). Three families of host PRRs involved in the recognition of
PAMPs are Toll-Like Receptors (TLRs), NOD-Like receptors (NLRs) and RIG-I like
receptors (RLRs). Regardless of the origin of PAMPs or the localization of PRRs, their
interaction results in an inflammatory response that serves as a first line of defense
3

against a wide variety of pathogens (Reviewed in [28]). On the flip side, the nonspecificity of innate immune response and the antimicrobial mediators produced by the
first responder cells such as neutrophils can result in severe damage to by-stander cells at
the site of acute inflammation. This causes the release of endogenous host factors in the
extracellular milieu. These endogenous molecules are termed alarmins, and typically
perform homeostatic functions when contained within cellular compartments. However
under pathological conditions, these molecules can be released either passively from dead
cells or actively via non-classical secretion pathways. Once in the extracellular milieu,
they exhibit immune modulatory properties such as induction of pro-inflammatory
cytokines, immune cell chemotaxis and regulation of cell death [29,30]. The interaction
of Toll-Like receptors (TLRs) as well as NOD-Like receptors (NLRs) with pathogen
derived PAMPs during sepsis has been studied extensively (reviewed in [28,31].
However, the recognition of self-molecules (alarmins) by signaling receptors and the
concomitant inflammatory response is an area of research which is still in its infancy. The
role of several alarmins such as High Mobility Group Box 1 (HMGB1) and S100 family
of calcium binding proteins has been demonstrated in various inflammatory conditions
[32,33]. However, in a complex immune disorder like sepsis which is an interplay of
several host immune pathways such as the coagulation system, complement cascade and
even the autonomic nervous system, it is likely that several alarmins are involved at the
intersections of these pathways. Thus, identification of novel alarmins and their receptors
may aide in understanding this complex disorder and may present additional targets for
effective therapeutics. Moreover, depending upon the type of infectious insults detected
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in septic patients, the identification of these alarmins and alarmin receptors may present
opportunities to customize the treatment options in septic patients.

Resolution of inflammation
Once the pathogenic insult has been taken care of, it is imperative that the immune cells
are cleared off the mileau, in order to restore the quiescent state of homeostasis. This is
achieved by the process of efferocytosis, where the innate immune cells such as
neutrophils, once they have completed their task of combating pathogens, start to undergo
apoptosis and are eventually phagocytosed by professional phagocytes in the vicinity
[34]. Deregulation of this process can result in secondary necrosis of these apoptotic
cells causing the release of host alarmins in the extracellular milieu which, we now know,
play an important role in exaggeration of an ongoing inflammation [35,36]. As sepsis is
often characterized by massive cell death in systemic organs, it is tempting to speculate
that a deregulation of efferocytosis process and turnover of neutrophils contributes to
sepsis development. However, studies correlating these two processes with sepsis are
surprisingly few. In addition to clearing dead cell carcasses, the process of efferocytosis
also modifies the phenotype of phagocytic cells from inflammatory to anti-inflammatory
nature resulting in production of host mediators such as TGF-beta and IL-10 that not only
shut the inflammatory response but also inhibit further influx of immune cells [37]. All of
these events constitute the complex process of resolution. In contrast to an initial belief of
resolution of inflammation being a passive process resulting from mere dilution of
chemokine gradients over time causing a cessation of cellular recruitment to the site of
injury, recent studies have revealed that the resolution of inflammation is a wellorchestrated active process [38]. Deficiency in any of its components may lead to over5

active, uncontrolled chronic inflammation. It is thus tempting to assume that, in the
context of an inflammatory disorder such as sepsis, this regulated process of resolution is
disrupted and progresses towards an accelerated and sustained condition of chronic
inflammation. This is an area of investigation which may hold some key answers to
queries regarding the mechanisms of sepsis development and how an otherwise beneficial
host response turns to a harmful process of excessive inflammation and overt tissue
destruction.

C-Type Lectins: Role in inflammation and resolution
Innate C-type lectins are emerging as immune determinants that can shape the balance
between inflammation and homeostasis. These are Ca++ dependent glycan-binding
proteins that share a homologous carbohydrate-recognition domain. With over 1000
members, the C-type lectin superfamily includes secreted as well as transmembrane
proteins. Most commonly expressed on the cells of myeloid origin, C-type lectin
receptors (CLRs) detect the PAMPs on microbes and, unlike TLRs, phagocytose the
microbes, leading to activation of tyrosine kinases which in-turn coordinate multiple
downstream signaling pathways leading to myeloid cell activation [39-41]. This has
implications not only for clearance of the internalized microbes via phagolysosomal
pathway and generation of innate immune mediators, but also for processing and
presentation of antigens to activate the adaptive immune system [42-44]. While in most
instances, this pathogen-binding capacity, internalization and signaling by CLRs
mediates host defense against infection, there is evidence that myeloid CLRs can be
exploited by pathogens to evade or suppress the immune response [45,46]. Beyond
pathogen binding, accumulating evidence now suggests that many CLRs can bind to
6

endogenous or self-molecules from damaged/altered cells, thus acting as sensors of injury
or cellular stress. For example, Mincle (Clec4e), a dectin-2 family CLR recognizes
SAP130, an alarmin released from damaged cells causing activation of inflammatory
response [47,48]. While Mincle has been shown to act in concert with another Dectin-2
family CLR Clec4d in recognition of mycobacterial PAMP and activation of
inflammatory response [49], the role of Clec4d in Mincle-mediated recognition of
alarmin SAP130 is unknown. MGL-1 and Lox-1 have been shown to bind to and
internalize aged and apoptotic cells [50,51]. These CLRs thus have been speculated to
play a role maintaining homeostasis. Furthermore, DC-SIGN and MGL have been shown
to bind tumor antigens and possibly contribute to tumor surveillance [52,53]. Mannose
receptor plays a role in clearance of mannosylated proteins from serum [54]. Apart from
membrane-bound CLRs, many soluble C-type lectins such as Collectins (Collagenous
Lectins) have also been shown to engage in recognition and clearance of apoptotic cells
[55-57]. The outcome of this interaction however, varies depending upon the tissue type
and the interacting proteins. For example, surfactant proteins in the immune-privileged
tissues such as lungs can opsonize and facilitate clearance of cellular material such as
DNA without evoking an immune reaction [58]. Involvement of complement proteins in
this soluble lectin mediated opsonization and phagocytosis, however, results in an
inflammatory response [59,60]. Despite these pleotropic functions in balancing the
inflammation and homeostasis, the role of CLRs in sepsis, a dynamic disease marked
with widespread cell death, inflammation and loss of homeostasis, is surprisingly
understudied.
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Another family of soluble lectins that has emerged as pleotropic regulators of immune
responses are Galectins (β-galactoside binding lectins). These are one of the most
ubiquitously expressed lectins which regulate a variety of inflammatory and homeostatic
processes such as cell growth, proliferation, cell-cell interaction, acute and chronic
inflammation and immune tolerance [61-63]. Interestingly, consistent with the property
of alarmins, galectins can be released by “leaderless”, non-classical secretion pathway
and play homeostatic roles in regulation of cell cycle and apoptosis, phagosome
formation and stabilization of intracellular signalling when contained in intracellular
compartments, but display inflammatory and T cell apoptotic activities upon extracellular
release [63,64]. Moreover, the extracellular release of galectins seems to correlate with
the virulence of invading pathogen [65], as well as influences immune responses through
chemotaxis and activation of innate immune cells [66]. Despite the progress in our
understanding of inflammatory properties of galectins, the role of these lectins as
alarmins in the development of sepsis disorder has not been studied.

Central Hypothesis
In light of these pleotropic immune regulatory functions of CLRs, the central hypothesis
of my dissertation proposal is that C-type lectin receptors regulate inflammatory response
in pneumonic sepsis by functioning as alarmins (soluble lectins) and alarmin receptors
(cell-surface CLR). Before joining my lab, a large scale screening of over 200 soluble
and membrane-bound CLRs in the lungs of mice undergoing pneumonic sepsis revealed
upregulation of several of these molecules at transcript level. My project involved
examination of the function of two soluble lectins Galectin-3 and -9 as putative alarmins
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and two membrane-bound lectins Mincle and Clec4d as putative alarmin receptors in
pneumonic sepsis.

Animal Models of Sepsis
Various animal models of sepsis have contributed significantly to our understanding of
host response and inflammatory cascade in the pathogenesis of sepsis. Endotoxemia
model developed by bolus injection of LPS mimics pathophysiological alterations
reported in sepsis patients to some extent, but the rapid and transient increase in
inflammatory cytokines in this model differs from a prolonged systemic response
observed in sepsis patients [67,68]. In fact it has been difficult to extrapolate the findings
of many endotoxin mouse models (cecal ligation puncture, colon ascendens stent
peritonitis) due to a relative resistance of mice to endotoxin shock in comparison with
humans [69-71]. We chose to utilize pneumosepsis model of pulmonary bacterial
infection because lung infections are a major source of sepsis in humans [72]. This model
produces detectable bacteremia, systemic organ damage and mortality with severe lung
pathology, observed in human patients. Two bacterial pathogens that we have used in our
studies are Klebsiella pneumoniae (KPn) and Francisella novicida (Fn). Pulmonary
infection of C57/BL6 mice with these pathogens causes bacteremia, extensive cell death
leading to sever lung pathology, hypercytokinemia and systemic organ dysfunction. The
excessive cell death is a hallmark of these pulmonary bacterial sepsis model infection,
regardless of the bacterial strain used [73] additionally, Dr. Sharma’s previous studies
showed Francisella infected phagocytes defective in efferocytosis, resulting in
accumulation of dead cells and their contents in the milieu [74]. We thus hypothesize that
during pneumosepsis host cells undergo death due to bacterial replication and
9

inflammatory response. Membrane-bound CLRs such as Clec4d and Mincle play a
protective role by mediating clearance of dead cells by phagocytes. On the other hand,
galectins released from dead cells play a pathogenic role and function as alarmins to
activate myeloid cells causing them to secrete proinflammatory mediators and
exacerbation of inflammatory response culminating in sepsis.
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Abstract
Sepsis is a complex immune disorder with a mortality rate of 20-50% and currently has
no therapeutic interventions. It is thus critical to identify and characterize
molecules/factors responsible for its development. We have recently shown that
pulmonary infection with Francisella results in sepsis development. As extensive cell
death is a prominent feature of sepsis, we hypothesized that host endogenous molecules
called alarmins released from dead or dying host cells cause a hyper inflammatory
response culminating in sepsis development. In the current study we investigated the role
of galectin-3, a mammalian β-galactoside biding lectin, as an alarmin in sepsis
development during F. novicida infection. We observed an upregulated expression and
extracellular release of galectin-3, in the lungs of mice undergoing lethal pulmonary
infection with virulent strain of F. novicida but not in those infected with a non-lethal,
attenuated strain of the bacteria. In comparison with their wild-type C57Bl/6
counterparts, F. novicida infected galectin-3 deficient (galectin-3-/-) mice demonstrated
significantly reduced leukocyte infiltration, particularly neutrophils in their lungs. They
also exhibited a marked decrease in inflammatory cytokines, vascular injury markers and
neutrophil associated inflammatory mediators. Concomitantly, in-vitro pre-treatment of
primary neutrophils and macrophages with recombinant galectin-3 augmented F.
novicida-induced activation of these cells. Correlating with the reduced inflammatory
response, F. novicida infected galectin-3-/- mice exhibited improved lung architecture
with reduced cell death and improved survival over wild-type mice, despite similar
bacterial burden. Collectively, these findings suggest that galectin-3 functions as an
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alarmin by augmenting the inflammatory response in sepsis development during
pulmonary F. novicida infection.
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Introduction
Sepsis results in 750,000 hospitalizations every year in the US and is the second leading
cause of mortality in patients admitted to intensive care units [75]. Pulmonary infections,
in turn, are a major cause of sepsis [76]. However, the mechanisms responsible are not
well understood. This is underscored by a lack of effective therapeutics against this
immune disorder despite more than two decades of active research. Our recent studies
have shown that pulmonary infection of mice with fully virulent Francisella tularensis as
well as the murine model organism F. novicida (F.n.) a Gram negative bacterial
pathogen, leads to development of severe sepsis characterized by hyperinflammation, T
cell depletion, and extensive cell death in systemic organs [73,77,78]. We are thus using a
murine inhalation model of F.n. infection to understand the mechanism/s responsible for
pulmonary infection-induced sepsis development.. Intriguingly, this pathogen is not
known to produce any exotoxin, which can account for the lethality of this infection.
Moreover, the lipid A of Francisella LPS does not stimulate TLR4 and is thus hypoinflammatory [79]. Studies from our and other laboratories have shown that extensive
tissue damage and wide-spread cell death is a hallmark of Francisella infection,
regardless of the bacterial strain [78,80-83]. Additionally, our studies show that
Francisella infected macrophages are defective in clearance of dead cell debris, a process
termed efferocytosis, leading to accumulation of these dead cells and their contents [74].
We thus hypothesized that in the absence of any bacterial toxins, host endogenous
molecules released from these dead or dying cells contribute to the inflammatory
response culminating in sepsis development during respiratory infection with Francisella.
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Alarmins are host endogenous factors which perform homeostatic functions when
contained within cellular compartments [29]. However, under pathological conditions,
these molecules can be released either passively from dead cells or actively via nonclassical secretion pathways [84]. Once in the extracellular milieu, they exhibit immune
modulatory properties such as induction of pro-inflammatory cytokines, immune cell
chemotaxis, and regulation of cell death [29,30,84]. The overt inflammation during sepsis
is primarily a result of the interaction between innate immune receptors with pathogen
derived molecules (Pathogen Associated molecular patterns (PAMPs) and alarmins.
PAMPs and alarmins together constitute Danger-Associated Molecular Patterns
(DAMPs). The interaction of Toll-Like receptors (TLRs) as well as NOD-Like receptors
(NLRs) with pathogen derived PAMPs during sepsis has been studied extensively
(reviewed in [26,31]. However, the recognition of self-molecules (alarmins) by signaling
receptors and the concomitant inflammatory response is an area of research which is still
in its infancy. Moreover, in a complex immune disorder like sepsis which is an interplay
of several host immune pathways such as the coagulation system, complement cascade
and even the autonomic nervous system [26], it is likely that several alarmins are
involved at the intersections of these pathways. Thus, identification of novel alarmins
may aide in understanding this complex disorder and may present additional targets for
effective therapeutics. As sepsis developed during pulmonary infection with Francisella
is associated with extensive cell death in lungs and other systemic organs, we sought to
identify novel alarmins that might be released during this infection and may contribute to
disease development.

15

Galectins constitute a soluble mammalian β-galactoside binding lectin family which play
homeostatic roles in regulation of cell cycle and apoptosis, as well as display
inflammatory and immune modulatory activities in various pathological conditions
[63,64,66,85]. Previous studies have implicated galectin-3 in regulation of various
inflammatory conditions including endotoxemia and airway inflammation [86-88]. In this
study we show that galectin-3, a mammalian galactoside binding soluble lectin is
upregulated and released in lungs of mice undergoing lethal respiratory infection with
F.n. but not in mice vaccinated with an attenuated mutant strain of the bacteria that
protects these mice from an otherwise lethal challenge. We thus hypothesized that
galectin-3 exacerbates the inflammatory response during lethal infection. The outcome
of this study, with use of galectin-3 deficient mice, shows that galectin-3 plays the role of
an alarmin in Francisella infection induced sepsis development.

Materials and Methods
Ethics Statement
The animal usage protocols were approved by the Institutional Animal Care and Usage
Committee at the University of North Dakota (protocol no. 1108-3) and the University of
Texas at San Antonio (protocol no. MU066). All the procedures strictly followed the
institutional and federal guidelines and all efforts were made to minimize animal
suffering.
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Bacterial strains and Mice
The F.n. strain U112 and an attenuated transposon mutant lacking a 58kDa protein of
hypothetical function (kindly provided by Dr. Larry Gallagher, University of
Washington) were grown on Trypticase Soy Agar (TSA) medium supplemented with Lcysteine at 37oC. After overnight growth, the bacteria were harvested and suspended in a
freezing medium (250 mM sucrose, 10 mM sodium phosphate pH 7.2 and 5 mM
glutamic acid). Stocks were aliquoted and frozen at -80oC for further use.
All in-vivo experiments were performed using 6-8 wk old female C57Bl/6 wild-type and
galectin-3

-/-

mice. Galectin-3

-/-

mice were purchased from Jackson Laboratories (Bar

Harbor, ME). Sex- and age-matched galectin-3+/+ mice with the same genetic background
were used as control.
Antibodies and Reagents
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For
detection of galectin-3 by immunofluorescence (IF) staining, a purified rat anti-mouse
galectin-3 antibody (eBioscience, San Diego, CA) followed by Alexa-546 conjugated
chicken anti-rat antibody (Molecular Probes, OR) was used. A rat anti-mouse CD11b
antibody conjugated to PE (BD Pharmingen) and a purified rat anti-mouse Gr1
monoclonal antibody, clone Ly-6G (Clone Accurate Chemical, Westbury, NY, USA),
followed by the secondary antibody RRX-conjugated Affipure goat anti-rat IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) were used for double staining of
activated

neutrophils.

The

terminal

deoxyribonucleotidyl

transferase-mediated

triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining kit was purchased from
Chemicon International, CA. Purified recombinant galectin-3 was purchased from R&D
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Systems, MN. The endotoxin level was <1.0 EU per µg of protein. For detection of
reactive oxygen species, Fc OxyBURST assay reagent was purchased from Molecular
Probes, Eugene, OR. Mouse IL-6 and TNF-α ELISA kits (BD OptEIA) were from BD
Biosciences, San Diego, CA.
Infection of Mice, survival and bacterial burden
Mice were anaesthetized with a mixture of ketamine HCL and xylazine (30mg/ml
ketamine, 4 mg/ml xylazine in PBS) and were infected intranasally with 50-70 CFUs of
the wild-type F.n.
strain U112 in 20 μl of PBS or with 20 µl of PBS alone. Mice were monitored daily for
signs of disease, which typically included piloerection, hunched gait, lethargy and eye
discharge. The survival of infected mice was recorded for up to 2 weeks post-infection
(p.i.). Mice displaying severe signs of distress (labored breathing, non-responsiveness to
cage tapping, failure of grooming and severe eye discharge) were humanely sacrificed by
injecting a mixture of ketamine (90-120mg/kg) and xylazine (10mg/kg) followed by
cervical dislocation. The death was recorded as tularemia induced mortality. For nonlethal infection, the mice were similarly inoculated with the mutant bacteria followed 3
weeks later by challenge with similar dose of the wild-type organisms. In some
experiments, the mice were euthanized at 3 days p.i. and blood, lungs and liver were
aseptically harvested. The organs were homogenized aseptically in cold PBS with
CompleteTM protease inhibitor cocktail (Roche Diagnostics, Germany). For the bacterial
burden analyses, the homogenates and blood were serially diluted in PBS and plated on
TSA. CFU counts per mouse were calculated after incubating the plates at 37 oC
overnight.
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Quantitative real-time PCR
Lungs from infected and mock control mice at various times post-infection were
immediately removed after perfusion and total RNA was extracted using Trizol reagent
(Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis of the
samples was performed using SYBR green (Applied Biosystems, CA, USA) as the
detection dye to measure the expression levels of Galectin-3-specific mRNAs. Briefly,
one microgram of total RNA from either infected or mock infected mice was reverse
transcribed into cDNA by using a high capacity cDNA reverse transcription kit according
to the manufacturer’s instructions (Applied Biosystems, CA, USA). Transcript levels of
the housekeeping ribosomal 18S and galectin-3 were PCR amplified in each sample by
using specific primers (Advanced Nucleic Acids Core Facility, UTHSCSA, TX): 18S
(sense)

5'-CATGTGGTGTTGAGGAAAGCA-3'

GTCGTGGGTTCTGCATGATG-3';

Gal-3
and

CAGTGCAGAGGCGTCGGGAAA-3’

and

(anti

sense)

(sense)
(anti-sense)

5'5'5’-

CTGCCCCAGCAGGCTGGTTT-3’. The target gene expression levels were normalized
to levels of the house keeping 18S gene in the same sample. Expression of galectin-3 in
infected samples was determined as fold change over that in control samples as
calculated by using the formula 2−(ΔΔCt).
Histological and Immunofluorescence staining
For histological and immunofluorescence staining, frozen lung tissues were processed as
previously described [77,82]. Frozen lung sections thus obtained were stained with
hematoxylin and eosin for pathological analysis, or for detection of galectin-3 and
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activated neutrophils (CD11b+Gr1+) by immunofluorescence staining, as previously
described [89] . For detection of cell death, TUNEL method was used according to
manufacturer’s instructions (Chemicon International, CA). The images were acquired
using a Leica DMR epifluorescent microscope (Leica Microsystems, Wetzlar, Germany)
with an attached cooled CCD SPOT RT camera (Diagnostic Instruments Inc., Sterling
Heights, MI). The images were processed and analyzed using Adobe Photoshop 7.0
software (Adobe, Mountain view, CA).
Enumeration of cellular infiltration in lungs
Lungs were harvested from infected and mock control mice at 3 days p.i. after perfusion
with PBS and were treated with collagenase to obtain single cell suspensions as
previously described [77,78,90]. Total numbers of viable immune cells in lungs of
infected and mock control galectin-3-/- or WT mice were counted by trypan blue
exclusion staining.
Multi-analyte profile analysis
The lung homogenates were prepared as described for the bacterial burden analysis above
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants
were immediately frozen at -80o C. The biomarker levels in lung homogenates were
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing
a multiplexed flow-based system: Mouse MAPTM (Multi-Analyte Profiles) analysis
technology.
Neutrophil and macrophage activation
Cells were isolated from the peritoneal cavities of naïve C57BL/6 mice 12-14h after
intraperitoneal injection with sterile 4% thioglycollate. Neutrophil percentage was
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determined by flow cytometry using neutrophil specific anti-mouse Gr-1 (anti-Ly-6G and
Ly6C). Additionally, the lavage cells were cytocentrifuged on glass slides and were
stained with H&E as described above. The cells were plated at the density of 1x106 cells
and were infected with wild-type F.n. strain U112 at MOI 50 with or without
pretreatment of the cells with 10µg/ml of purified recombinant galectin-3.

Cells

stimulated with galectin-3 alone or with 10ng/ml of phorbol myristate acetate (PMA)
served as controls. One hour after stimulation, production of reactive oxygen species
(ROS) was measured in the cells by flow cytometry using Fc OxyBURST reagent
according to the manufacturer’s instructions. A minimum of 10,000 events was read for
each sample and all the cells fluorescing positive in FITC channel (excitation and
emission maxima of ~490 nm and ~520 nm, respectively) were gated to get the
percentage of ROS producing cells.
Bone marrow was isolated from wild-type and galectin-3-/- mice and the cells were
differentiated to macrophages as previously described [91]. On day 6 of culture 90-95%
cells were macrophages as determined by flow cytometry using macrophage specific
markers CD11b and F4/80. The cells were plated at 8×104 cells per well in 96-well flatbottom plates and were stimulated as described above for the neutrophils. Culture
supernatants were collected 24h after stimulation and measurement of IL-6 and TNF-α
was performed by ELISA according to the manufacturer’s instructions (BD OptEIA, BD
Biosciences).
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Statistical Analysis
Survival of the infected wild-type and galectin-3-/- mice was compared using Kaplan
Meier log Rank test. Statistical comparison between levels of host mediators in different
experimental groups was performed by Student’s t test using Sigma Plot 8.0

Results
Galectin-3 is highly expressed and is localized extracellularly in lungs during the septic
phase of F.n. infection.
Alarmins are characterized as intracellular host factors which display extracellular release
under pathological conditions. To examine if galectin-3 exhibits this alarmin property in
pulmonary tularemia, the expression and distribution of this lectin was analyzed. We
compared the transcript and protein level expression of galectin-3 at various times postinfection (p.i.) in lungs of mice undergoing lethal pulmonary infection with the wild-type
strain of F.n. versus the mice vaccinated with an attenuated mutant of F.n. (Mut/WT
mice), which protects the mice from sepsis. This mutant has been characterized
extensively in our previous studies [77]. As shown in Figure 1A, galectin-3 transcript
levels showed maximal increase at 3 days p.i. (dp.i.) in the lungs of mice infected with
the wild-type bacteria as well as in the Mut/WT mice. However, this increase was
significantly higher in mice undergoing lethal infection as compared to the protected
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Figure 1. Upregulated expression and extracellular release of Galectin-3 in lungs
during respiratory F. novicida infection
. (A) Total RNA was extracted by Trizol method from lungs harvested at the indicated
times after infection with the Wild-type bacteria (WT) or from mice vaccinated with an
attenuated mutant strain followed by challenge with WT bacteria (Mut/WT mice). The
mRNA levels of Galectin-3 were analyzed by real-time PCR as described in Materials
and Methods and are expressed as fold changes over the levels in mock control mice. Data
shown are the averages of 3- 4 mice per group. Statistically significant differences are denoted by
asterisks (**, p<0.005). (B) In-situ IF staining of frozen lung sections from mock infected and
WT U112 infected or Mut/WT mice harvested at 3 d. p.i

Lung harvested 3 weeks after

vaccination with the mutant alone (Mut-3wk) served as controls for Mut/WT mice. The sections
were stained for galectin-3 (red) using a purified rat anti-mouse galectin-3 antibody followed by
Alexa-546 conjugated chicken anti-rat antibody. Nuclei (blue) were stained with 4’6’ diamidino2-phenylindol-dilactate (DAPI). Magnification X 200. Insets depict extracellular galectin-3 in
WT F. novicida infected mouse lungs (B2’) and cytosolic galectin-3 in Mut/WT (B4’) mouse
lungs.
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Mut/WT mice. This increase in galectin-3 expression at 3 dp.i. is consistent with the
appearance of other sepsis features (extensive cell death, hyperinflammatory response,
increased vascular injury) at this time, as shown in our previous studies with F.n. as well
as the fully virulent F. tularensis [77,78]. We thus termed this as septic phase of
Francisella infection and carried out the rest of our analysis at this time point.
Immunofluorescence (IF) analysis of galectin-3 protein expression in frozen sections of
lungs harvested at 3dp.i. showed a low basal level expression in mock infected mice
inoculated with PBS alone (Fig. 1.B1). Consistent with the transcript data, lungs of mice
undergoing septic infection with the wild-type F.n. exhibited upregulated expression of
this lectin at 3d p.i. (Fig. 1. B2). This increase in expression was substantially higher than
that in Mut/WT mice (Fig.1.B4). The mice infected with mutant alone for 3 weeks and
without challenge with WT bacteria (Mut-3wk) served as control for the Mut/WT mice.
In these mice, galectin-3 was observed to be expressed at low basal level similar to mock
control animals (Fig. 1B3). Importantly, most of galectin-3 expressed in septic mice was
localized extracellularly in large granuloma-like areas of cellular infiltration, undergoing
extensive cell death (Fig. 1.B2’). The non-septic Mut/WT mice, on the other hand,
showed intracellular galectin-3 associated with live cells (Fig. 1.B4’). Western blot
analysis of bronchoalveolar lavage (BAL) from mice infected with the WT F. novicida
also showed a significantly high extracellular release of galectin-3 (Fig. 2). Taken
together, these data clearly showed that galectin-3 exhibits a characteristic alarmin
property of extracellular release during septic phase of pulmonary F.n. infection.
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Figure 2. Upregulated expression and extracellular release of Galectin-3 in lungs
during respiratory F. novicida infection.
Bronchoalveolar lavage (BAL) was obtained from lungs of mice infected with the wildtype F. novicida strain U112 or PBS alone as previously described (9). Galectin-3 was
immunoprecipitated from BAL using a purified rat anti-mouse galectin-3 antibody
(eBioscience, San Diego, CA) by previously described method [92] with modifications.
Briefly 1 mg of total BAL proteins were incubated with 10 µg anti-galectin-3 antibody at
4oC overnight. Immune complexes were pulled down with using 30 μl of 30% Protein A
Plus agarose beads (Pierce) for 2h at 4oC. The beads were washed, solubilized in 1× SDS
gel loading buffer and resolved on 12% acrylamide gels (BioRad). The gels were
processed for western blotting as described previously [77] for detection of galectin-3
using anti-mouse galectin-3 antibody. Densitometric analysis of bands was performed
using the Lumi-Imager software (Roche Applied Science). Bar graph depicts
densitometry analysis of galectin-3 bands represented in arbitrary units. Statistically
significant differences are denoted by asterisks (***, p<0.001).
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F.n. infected Galectin-3-/- mice display reduced inflammatory response and
neutrophil accumulation
We hypothesized that, similar to the function of alarmins, increased expression and
extracellular localization of galectin-3 may be contributing to the hyperinflammatory
response culminating in sepsis during lethal Francisella infection. In order to analyze
this, lungs were harvested at 3d.p.i. from F.n. infected galectin-3-/- and wild-type mice
and the levels of multiple cytokines, chemokines as well as vascular injury markers were
measured using a multiplex assay. Galectin 3-/- mice displayed significant reduction in
levels of several vascular injury markers in comparison with their wild-type counterparts
(Fig. 3A). In addition, levels of several inflammatory cytokines (TNF-α, IL-10, IL-1β),
described as markers of sepsis, were reduced in galectin-3-/- mice (Fig. 3B). These
observations strongly suggested an immune-stimulatory role of galectin-3 during
pulmonary Francisella infection. Interestingly, in comparison with wild-type mice,
infected galectin-3-/- mice displayed a reduction in several chemokines involved in
neutrophil recruitment (Fig. 3C). Furthermore, levels of myeloperoxidase (MPO), a
neutrophil associated protease and marker of neutrophil activation, was also reduced in
infected galectin-3-/- mice. In order to correlate these observations with cellular
infiltration in-vivo, IF staining for co-expression of CD11b and Gr1, markers for
activated neutrophils [93], was performed on lung sections from galectin-3-/- and wildtype mice. Consistent with the chemokine data, cells infiltrating the lungs of infected
wild-type mice showed high co-expression of CD11b and Gr1, suggesting an activated
neutrophil phenotype. These cells were mostly accumulated in large lesion like areas in
the lungs of these mice. The cells in infected galectin-3-/- mice, on the other hand,
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Figure 3. Galectin-3-/- mice display reduced levels of inflammatory mediators in
lungs after pulmonary infection with F.n.
The lungs from WT mock infected (WT-M), galectin-3-/- mock infected (Gal-3-/-M), WT
F. novicida infected (WT-Inf) or galectin-3-/- F. novicida infected mice (Gal3-/-Inf) were
harvested at 3 d.p.i., homogenized with protease inhibitors in PBS and analyzed
commercially for rodent multi-analyte profiles (Rules-Based Medicine, Austin, TX). (A),
levels of vascular injury markers; (B), levels of inflammatory cytokines; and (C), levels
of neutrophil attractant chemokines and activation markers in lung homogenates. Results
shown are from 3-4 mice per group from 3 different experiments. CRP; C-reactive
protein, MMP-9; matrix metalloproteinase-9, MPO; myeloperoxidase. * p<0.05; **
p<0.00.
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Figure 4. Galectin-3-/- mice display reduced accumulation of neutrophils in lungs
during F.n. infection.
Frozen sections of lungs harvested at 3 d. p.i. from mock infected and F. novicida
infected WT or galectin-3-/- mice were co-stained with antibodies against myeloid cell
markers CD11b (red) and Gr1 (green). A high co-expression of both markers is depicted
by yellow color in infected WT lungs while cells infiltrating lungs of galectin-3-/- mice
exhibited expression of only CD11b. Nuclei (blue) were stained with 4’6’ diamidino-2phenylindol-dilactate (DAPI). Magnification X 200. Asterisks depict lesions in the lungs.
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expressed CD11b, but low or no Gr1 (Fig. 4). These results suggested a role of galectin-3
in regulation of myeloid cell accumulation, particularly neutrophils, in the lungs of mice
during pulmonary F.n. infection.
Galectin-3 regulates F.n. infection induced inflammatory response in-vitro
In order to further investigate the immune stimulatory properties of galectin-3, we
examined the role of this lectin in in-vitro activation of myeloid cells, particularly
neutrophils and macrophages. These are the major cell types that infiltrate the lungs of
Francisella infected mice [77,94]. In-vitro infection of WT bone marrow derived
macrophages (BMDMs) with wild-type F.n. U112 resulted in an inflammatory response
in terms of increased TNF-α and IL-6 production (Fig. 5A). Galectin-3-/- macrophages on
the other hand, produced significantly lower amounts of these cytokines in response to
infection (Fig. 5A). As the extracellularly released galectin-3 may be playing a role in
activation of myeloid cells in-vivo, we examined if pretreatment of these cells with
galectin-3 has any effect on Francisella infection induced cytokine production.
Stimulation of macrophages with purified galectin-3 induced minimal amount of TNF-α
and IL-6 production (Fig. 5B). The optimal concentration of galectin-3 was
experimentally determined by using 1-20µg/ml of the recombinant protein (data not
shown). Infection with wild-type F.n. strain U112 infection, on the other hand, induced
substantial amounts of these cytokines in macrophages. Interestingly, pre-treatment of
macrophages with purified galectin-3 exacerbated this Francisella-induced inflammatory
cytokine production (Fig. 5B). Immune stimulatory effect of galectin-3 was also
examined on peritoneal neutrophils. Cells collected by peritoneal lavage following
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Figure 5. Galectin-3 regulates F.n. infection induced inflammatory response in-vitro.
(A). Bone marrow derived macrophages (BMDMs) were isolated from wild-type and
galectin-3-/- mice as described in Methods. The cells were infected with wild-type F.n.
Strain U112 at MOI of 50 and the culture supernatents were collected 24h after infection.
The amount of TNF-α and IL-6 were measured in the supernatents by Sandwich ELISA.
(B). BMDMs from C57Bl/6 wild-type mice were infected with wild-type F.n. Strain
U112 at an MOI of 50 with or without pretreatment with 10µg/ml of purified
recombinant galectin-3. Culture supernatants were collected 24h after infection and the
amount of TNF-α and IL-6 were measured by ELISA. The experiment was repeated three
times with similar results. (C). Peritoneal neutrophils were isolated from mice 12-14h
after injection with 4% thioglycollate and were stimulated with F. novicida at an MOI 50
with or without pre-treatment with purified recombinant galectin-3 (10µg/ml).
Stimulation with galectin-3 alone or phorbol myristate acetate (PMA, 10ng/ml) was used
as a control. Production of reactive oxygen species was measured one hour poststimulation by flow-cytometry using Fc-OxyBURST dye following the manufacturer’s
instructions. Numbers in black on the plots depict percent of ROS positive cells and the
numbers in green represent median fluorescence intensity (MFI) of individual cells. Dot
plots from a representative of 3 independent experiments are shown.
Statistical analysis between the data sets was performed by Student’s t test where **p <
0.005; ***p < 0.001.
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Figure 6. Flow cytometry analysis of peritoneal neutrophils.
Mice were injected intraperitoneally with sterile 4% thioglycollate. Peritoneum was
lavaged 12-14hrs later and cells were analyzed by flow cytometry using neutrophil
specific anti-mouse Gr1 (Ly6G+Ly6C) antibody. In addition, cells were cytocentrifuged
and stained with H&E for morphological analysis.
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intraperitoneal injection of thioglycollate were 80-85% neutrophils as determined by flow
cytometry and morphological analysis with characteristic multilobed nuclei (Fig. 6).
Unlike macrophages, treatment of neutrophils with purified galectin-3 alone activated
these cells to produce substantial levels of ROS as determined by oxidation of Fc
OxyBURST dye (Fig. 5C). Importantly, pre-treatment of neutrophils with this lectin
primed these cells to produce further increased amounts of ROS in response to F.n.
infection, which was significantly higher than that elicited by F.n. infection alone (Fig.
5C). This cell-type specific response of galectin-3 indicates involvement of distinct
receptors and/or signaling pathways, which is currently being investigated in our
laboratory. Nonetheless, this augmentation of Francisella infection-induced myeloid cell
activation by galectin-3 likely has implications in exacerbation of inflammation
culminating in sepsis development during this infection.
Galectin-3-/- mice exhibit reduced lung pathology after F.n. infection.
Lung cryosections from wild-type and galectin-3-/- mice infected with a lethal dose of
F.n. were stained with H&E and processed for histopathological analyses as described in
Materials and Methods. Mock infected wild-type and galectin-3-/- mice exhibited similar
normal lung architecture with minimal cellular infiltration and clear air spaces (Fig. 7A).
As expected, a massive increase in cellular infiltration and extensive pathology, along
with severe bronchopneumonia and massive cell death occurring in the center of large
granuloma-like areas of infiltration, was evident in the lungs of wild-type mice at 3 dp.i.
(Fig 7A).

The lungs of galectin-3-/- mice, on the other hand, showed moderate

peribronchial and perivascular infiltration (Fig. 7A). The infiltrating cells in these areas
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Figure 7. Galectin-3 deficiency leads to improved lung pathology, reduced leukocyte
accumulation and reduced cell death upon pulmonary F.n. infection.
(A) Lungs from mock infected and F.n. infected wild-type (WT) or galectin-3-/- mice
were harvested at the septic phase (3 d. p.i.), embedded in optimal-cutting-temperature
(OCT) compound, and sectioned as described in Materials and Methods. The frozen
sections were stained with Hematoxylin and Eosin. The images obtained are
representatives of three experiments performed, and in each experiment each group
contained three mice. Magnification, ×200. (B). Lungs from mock infected and F.n.
infected WT or galectin-3-/- mice were harvested 3 days after intranasal infection. Total
immune cells infiltrating the lungs were isolated by collagenase treatment of lungs as
described in Materials and Methods. Total numbers of viable immune cells were counted
by trypan blue exclusion staining (n = 5-6). Statistical analysis between the data sets was
performed by Student’s t test where **p < 0.005. (C). Frozen lung sections from mock
infected and Francisella infected WT or galectin-3-/- mice were processed for in-situ
TUNEL staining for detection of DNA fragmentation (red) in nuclei. Nuclei (blue) were
stained

with

4′,6′-diamidino-2-phenylindole
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dilactate.

Magnification,

×100.
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appeared to be viable and the areas of infiltration lacked cellular debris that is typical of
extensive apoptosis and necrosis in the wild-type mice. This was consistent with reduced
numbers of leukocytes enumerated after collagenase treatment of the lungs harvested
from galectin-3-/- mice (Fig. 7B). Galectin-3 deficiency did not affect the basal number of
cells as mock infected wild-type and galectin-3-/- animals showed similar low number of
cells in the lungs. To further analyze the extent of cell death in the lungs of infected wildtype and galectin-3-/- mice, TUNEL assay was performed on frozen sections of lungs
harvested at 3 dp.i. As shown in Fig. 7C, mock infected wild-type and galectin-3-/- mice
showed minimal numbers of TUNEL positive cells in their lungs. On the other hand,
septic lungs of F.n. infected wild-type mice showed extensive cell death within
perivascular and peribronchial lesions which are the main sites of immune cell infiltration
during infection (Fig. 7C). In contrast, the numbers of apoptotic TUNEL positive cells in
infected galectin-3-/- mice were much less as compared to their wild-type counterparts
following infection with F.n. The improved lung architecture and reduced cell death in
the absence of galectin-3 indicates a pathological role of this lectin during pulmonary
Francisella infection.
Galectin-3-/- mice show improved survival following F.n. infection.
In order to see the effect of improved lung pathology and reduced inflammatory
responses in the absence of galectin-3, overall disease severity and survival was
compared in C57BL/6 wild-type and galectin-3-/- mice infected with a lethal dose of F.n.
In the infected wild-type mice, visible signs of disease started to appear by day 3 p.i.
which typically included piloerection, hunched gait, lethargy, and eye discharge. All of
these mice succumbed to infection by day 5 p.i. (Fig. 8A). By contrast galectin-3-/- mice
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Figure 8. Galectin-3-/- mice show improved survival during pulmonary F.n.
infection.
(A). Fifteen C57Bl/6 WT and 17 galectin-3-/- mice in 3 separate experiments were
inoculated intranasally with F. novicida and were monitored for survival daily for 2
weeks. The improved survival of galectin-3-/- mice compared to WT mice was
statistically significant, as determined by Kaplan-Meier log-rank analysis (P value*** =
0.0003). (B) Bacterial burdens in lungs harvested from F. novicida infected WT and
galectin-3-/- mice at 3 d.p.i. Lungs and liver were harvested from infected mice,
homogenized as described in Materials and Methods. Tissue homogenates and blood
harvested at the same time, were serially diluted and plated on TSA plates to enumerate
bacterial burdens. In this representative of three independent experiments, each group
contained three to five mice.
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exhibited delayed appearance of disease symptoms and showed significantly improved
survival as compared to the infected wild-type mice (Fig. 8A). Intriguingly, enumeration
of bacterial burden in the organs of these mice at the peak of infection, i.e., 3 d.p.i.
showed that both galectin-3-/- and the wild-type animals exhibited similar bacterial
burdens in their systemic organs as well as in blood (Fig. 8B).

Discussion
Sepsis is the 2nd leading cause of death in ICU patients and pulmonary infections in turn
are a major source of sepsis [5]. It is a complex immune disorder resulting from
deregulation of multiple host defense pathways. Accumulating evidence suggests that
host endogenous molecules termed alarmins, likely play an important role in
pathophysisology of sepsis [95]. In this study we show that galectin-3, a mammalian βgalactoside binding lectin acts as a novel alarmin in development of sepsis during
pulmonary infection with F. novicida. Consistent with characteristic properties of
alarmins, galectin-3 was upregulated and extracellularly released during the septic phase
of infection and could amplify the Francisella infection-induced inflammatory response
of neutrophils and macrophages. Furthermore, galectin-3-/- mice showed improved
pathology, reduced inflammation and improved survival during pulmonary Francisella
infection. These results suggest that galectin-3 functions as an alarmin and plays a
pathogenic role in development of sepsis in pulmonary bacterial infection.
Alarmins are structurally diverse multifunctional host proteins with some common
properties (12-15). These are endogenous proteins performing homeostatic functions that
lack any signal sequence for active secretion and have chemoattractant and immune
activating properties, once released in extracellular milieu. With advances in our
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understanding of host responses to pathogenic events, the list of alarmins has continued
to grow over the past decade. Several well characterized alarmins such as High Mobility
Group Box1 (HMGB-1), S100 family of proteins, and heat shock proteins have been
shown to perform dual functions as factors controlling homeostatic processes like
transcriptional regulation when localized to intracellular compartments and as proinflammatory factors upon their release from necrotic cells during a pathogenic insult
[32,33,96]. Similarly, galectin-3 when localized in the nucleus, has been shown to act as
an RNA splicing factor [97] and performs homeostatic functions such as embryogenesis
and cell cycle regulation [63]. The results of current study showed that galectin-3 can be
released extracellularly in lungs under pathogenic conditions such as an infection.
Curiously, galectin-3 does not contain any signal sequence for golgi mediated classical
secretion. Thus active secretion of this lectin is likely via a yet unclear non-classical
secretion pathway, a property shared by most alarmins characterized to date [66].
However, in F.n. infection, this lectin is likely released passively from dead/dying cells
since the extracellular galectin-3 is detected only during lethal infection with F.n., which
typically results in extensive cell death [77,78,80]. On the other hand, the mice
vaccinated with an attenuated F.n. mutant causing little or no cell death showed this lectin
to be intracellular and largely associated with live cells, with minimal levels in BAL.
Notwithstanding the mechanism involved, release of galectin-3 in the septic phase of F.n.
infection indicates a role for this molecule in pathogenesis of this infection.
Consistent with alarmin properties, galectin-3 exhibited immune activating properties
such as stimulation of oxidative burst in neutrophils and inflammatory cytokine
production in macrophages. Importantly, this lectin was able to augment F.n. infection
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induced inflammatory response from neutrophils as well as macrophages, which can have
important implications under in-vivo conditions. Previous studies from our laboratory
have shown that pulmonary infection with F.n., as well as F. tularensis, results in
extensive cell death and that F.n. infected phagocytes are defective in efferocytosis, the
process of clearing dead cell debris [74]. Coinciding with this, we have further shown
that pulmonary Francisella infection is characterized by hyperinflammatory response
with an unbridled increase in levels of several inflammatory cytokines as well as vascular
injury markers [77,80]. It is likely that during pulmonary Francisella infection, galectin-3
released from these dead cells primes the bystander myeloid cells to produce heightened
levels of inflammatory mediators in response to the bacteria, resulting in further tissue
damage and ultimately organ failure, characteristic of sepsis. Curiously, while the
macrophages did not respond to galectin-3 alone, neutrophils displayed ROS production
upon stimulation with galectin-3 or F.n. infection alone, which was amplified upon
combination of the two. This cell-specific nature of galectin-3 activity in the context of
Francisella infection is interesting and is in line with a previous study showing the role of
prototype alarmin HMGB1 in promoting the inflammatory response of monocytes
elicited by external stimuli [98]. Intriguingly, in that study as well, the monocytes did not
respond to HMGB1 alone. In light of several biologically
distinct functions performed by alarmins ranging from inflammation to tissue repair and
wound healing, association with other stimuli possibly adds another layer to the
regulation of their mechanisms of action. Although speculative at this stage, it is possible
that the activating receptor for galectin-3 on neutrophils is constitutively expressed while
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that on macrophages likely gets expressed in an infection-specific manner. Further
studies to test this hypothesis are currently underway in our laboratory.
As mentioned earlier, one of the characteristic properties of alarmins is to mediate
immune cell influx. The reduced number of leukocytes in infected galectin-3-/- animals in
this study indicates that this lectin likely plays a role in recruitment of these cells in
sepsis. Reduced levels of neutrophil chemoattractants and activation markers in galectin3-/- mice support this notion. This observation is in line with the role of prototypic
alarmin HMGB1 in neutrophil migration by regulating the levels of chemoattractants
such as IL-8 [99]. Additionally galectin-3 may also play a direct role in extravasation of
neutrophils from blood vessels into the lungs, as shown in a previous study with
pulmonary S. pneumonia infection [65]. Other proinflammatory alarmins such as S100
proteins have also been shown to directly promote migration of myeloid cells by binding
to their cell surface receptors [100,101]. Another possibility is that galectin-3 may have a
role in inhibiting neutrophil turnover. Under the conditions of a resolving inflammatory
response to an infectious insult, once the neutrophils have performed their antimicrobial
function, they undergo programmed cell death. The failure of this process is the root
cause of several inflammatory disorders, as prolonged exposure to neutrophilic factors
can result in non-specific tissue damage [102]. In this regard a recent study showed a
defect in neutrophil turnover and thus the lack of resolution of inflammation during
Francisella infection [103]. Furthermore, a previous study has shown the involvement of
galectin-3 in decreasing neutrophil death as well as reducing macrophage cell death in
response to apoptotic stimuli [104,105]. This suggests that expression of galectin-3 in
inflammatory cells may lead to their enhanced survival, resulting in exacerbated
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inflammation. Thus it is tempting to speculate that galectin-3, in addition to activating
neutrophils, may be playing a role in inhibition of neutrophil turnover during Francisella
infection by prolonging the lifespan of these cells. Consistent with this hypothesis, F.n.
infected galectin-3-/- mice show reduced numbers of neutrophils, lower levels of
neutrophil associated immune mediators and consequently reduced tissue pathology.
These observations further support proinflammatory and pathogenic role of galectin-3 in
pulmonary F.n. induced sepsis.
Extensive tissue pathology is a major complication of acute respiratory infections which
are associated with severe sepsis [106,107]. This is caused by hyper activation of the
inflammatory immune response that results in capillary leakage, tissue injury, and
ultimately lethal organ failure [108,109]. Results from the current study showed that F.n.
infected galectin-3-/- animals exhibited a reduction in the levels of sepsis mediators such
as vascular injury markers thrombopoietin, fibrinogen, as well as acute phase protein
CRP and inflammatory cytokines such as TNF-α, IL-6 and IL-1. This observation further
suggested that galectin-3 mediates upregulation of these sepsis markers during
Francisella infection and thus plays a role in development of sepsis. As a result of this
mitigated inflammatory response and tissue pathology, galectin-3-/- mice are able to
survive the infection for a significantly longer duration as compared to infected wild-type
mice. Galectin-3-/- mice have been shown to be highly resistant to infection with another
Gram negative bacterium Salmonella [86] with KO mice exhibiting lower bacterial
burdens. Although the mechanism of this protection was not shown, it was speculated
that galectin-3 binds to and masks bacterial PAMPs resulting in immune suppression and
unchecked bacterial growth. Previous studies have shown the ability of galectin-3 to bind
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to a variety of pathogens [110-113] owing to its specificity for β-galactosides which are a
common constituent on pathogen membranes. This interaction can serve to activate
immune response as well as result in direct killing of the pathogen as shown in case of
Candida [112]. Since we observed similar bacterial burdens in F. novicida infected
galectin-3-/- and wild-type mice, it seems unlikely that galectin-3 is involved in direct
killing of bacteria. It is, however, possible that galectin-3 could be binding to a
Francisella factor thus potentiating its interaction with immune activating receptor/s, as
has been shown in case of HMGB1 [98]. Studies regarding the identity of Francisella
factors possibly engaged by galectin-3 and immunological consequences of these
interactions are currently on-going in our laboratory. The survival advantage of F.
novicida infected galectin-3-/- was observed to be only transient as these mice ultimately
succumbed to infection, possibly due to overwhelming bacterial burdens. Interestingly,
this survival advantage of galectin-3-/- mice was dependent on the infection dose of
bacteria. The galectin-3-/- mice succumbed to the infection at a similar rate as WT mice
when infected with 300-500 CFUs of bacteria (data not shown). It is possible that at that
dose, a higher bacterial burden leads to a further increase in cell death leading to an
increased accumulation of other alarmins which mask the advantageous effect of the
absence of galectin-3. This observation highlights the complex nature of sepsis syndrome
where multiple host and pathogen derived factors cross talk and regulate various immune
pathways. It is also consistent with previous studies showing partial or no protection upon
blocking single alarmin such as HMGB1 [114-116]. Nonetheless, as the bacteria can be
cleared by successful antibiotic therapy, the complications often arise from tissue damage
during sepsis. Thus, a combinatorial approach using blockage of galectin-3 along with
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antibiotics could prove to be a successful therapy for treating Francisella infection
induced sepsis.
In Toto, our findings indicate that galectin-3 plays a pathogenic role as an alarmin to
exacerbate the inflammatory response during pulmonary infection with Francisella and
contributes to sepsis development. Galectin-3 thus may represent a potential target for
treatment of sepsis during this infection.
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Abstract
Pneumonia is frequently associated with sepsis characterized by a non-resolving
hyperinflammation. However, specific host components of the pulmonary milieu that
regulate the perpetuation of inflammation and tissue destruction observed in this immune
disorder are not clearly understood. We examined the function of Clec4d, an orphan
mammalian C-type lectin receptor, in Gram pneumonic sepsis caused by Klebsiella
pneumoniae. While the wild-type mice infected with a sublethal dose of bacteria could
resolve the infection, the Clec4d-/- mice were highly susceptible with a progressive
increase in bacterial burden, hyperinflammatory response typical of sepsis and severe
lung pathology. This correlated with a massive accumulation of neutrophils in lungs of
infected Clec4d-/- mice which was in contrast with their wild-type counterparts where
neutrophils transiently infiltrated the lungs. Interestingly, the Clec4d -/- neutrophils did
not exhibit any defect in bacterial clearance. These results suggest that Clec4d plays an
important role in resolution of inflammation, possibly by facilitating neutrophil turnover
in lungs. This is the first report depicting physiological function of Clec4d in a
pathological condition. The results can have implications not only in sepsis but also other
inflammatory diseases where non-resolving inflammation is the root cause of disease
development.

48

Introduction
Sepsis poses a major health care burden with 750,000 cases annually in the United States
with a mortality rate of 20-50% [5]. Currently there are no effective therapies to treat this
deadly immune disorder. Pneumonia is the most frequent source of sepsis [117]. In that
regard, nosocomial infections caused by the opportunistic pathogen Klebsiella
pneumoniae (KPn) account for 5-20% of Gram-negative sepsis cases. In light of constant
occurrence of antibiotic resistant strains of this pathogen, an understanding of functioning
of host innate immune components might provide targets for modulation of host immune
system in a beneficial manner [118,119].
Sepsis is now perceived as interplay of pathogen derived (pathogen associated molecular
patterns, PAMPs) as well as endogenous host factors (termed alarmins [120]. C-type
lectin receptors (CLRs) are emerging as pattern recognition receptors which can shape
immune responses by recognizing a variety of PAMPs as well as alarmins [121].
However, their function in development of sepsis is largely unexplored. In that regard,
Clec4e (Mincle) of Dectin-2 subfamily has recently been shown to function as an
activating receptor for host endogenous factors released from dead cells and PAMPs of
bacterial and fungal origin [49]. Clec4d, another Dectin-2 family member is localized
close to Mincle in NK gene complex region of chromosome 12p13 and its function is yet
to be defined [122,123]. Based on the close vicinity of this receptor with Mincle, we
hypothesized that it likely plays a role in regulating immune responses during pathogenic
conditions.
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In this study we tested the role of Clec4d in Gram negative sepsis induced by pulmonary
infection with KPn. Our results show that Clec4d-mediated responses are required for the
resolution of pneumonia and to mitigate mortality in pulmonary KPn induced sepsis. This
may have implications for other immune disorders associated with non-resolving,
persistent inflammation.

Materials and Methods
Infection of mice and survival
Six to 8 weeks old female wild-type C57BL/6 and Clec4d-/- mice (obtained from the
Consortium of Functional Genomics) bred in the animal facility of the University of
North Dakota were used according to institutional and federal guidelines. Mice were
infected intranasally with sublethal dose (5 x 104 bacteria in 20ul of saline, determined
experimentally) of KPn (ATCC strain 43826). The bacteria were grown to log phase in
LB medium. Mock infected mice received saline only. Mice were monitored daily for
signs of disease, which typically included piloerection, hunched gait, lethargy, weight
loss and increased respiratory rate. The survival of infected mice was recorded for up to 2
weeks post-infection (p.i.).
Bacterial Burden and Multi-analyte profile analysis
Lungs and livers from infected and mock mice at various times post-infection (p.i.) were
immediately removed after perfusion were homogenized aseptically in cold PBS with
CompleteTM protease inhibitor cocktail (Roche Diagnostics, Germany), all described by
us previously [77,124]. For the bacterial burden analyses, the organ homogenates and
blood were serially diluted in PBS and plated on LB agar. The immune mediators in lung
homogenates were determined commercially by Myriad Rules-based Medicine (Austin,
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TX, USA) utilizing a multiplexed flow-based system: Rodent MAPTM (Multi-Analyte
Profiles) analysis technology.
qRT-PCR
Lungs from infected and mock mice at various times post-infection (p.i.) were
immediately removed after perfusion and were used to extract total RNA by Trizol
reagent (Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis
of the samples was performed, as described previously [124] using SYBR green (Applied
Biosystems, CA, USA) to measure the expression levels of Clec4d-specific mRNAs by
using specific primers Clec4d (sense) 5'- GAA CAA ATT CTT GCC GTC CTG ACC-3’
and (anti-sense) 5’-TCC ATC ACA AGG ACC ACT TTC TGA G-3’ (Integrated DNA
Technologies, Inc., Iowa). The target gene expression levels were normalized to levels of
the house keeping 18S gene (sense) 5'-CATGTGGTGTTGAGGAAAGCA-3' and (anti
sense) 5'-GTCGTGGGTTCTGCATGATG-3' in the same sample. Expression of Clec4d
in infected samples was determined as fold change over that in control samples as
calculated by using the formula 2−(ΔΔCt).
Histological Analysis
Lungs from infected and mock mice at various times post-infection (p.i.) were isolated
after perfusion were snap-frozen in OCT resin. For pathological analysis 10 µm thick
serial horizontal sections of frozen lungs were stained with hematoxylin and eosin (H&E)
as described previously [77].
Flow Cytometry
For enumeration of neutrophils by flow cytometry, lungs from mock control and infected
animals isolated 3 days p.i. (dp.i.) were processed to get total cellular infiltrates as
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previously described by us [77]. Ly6G+CD11b+ neutrophils were quantified using
Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G antibodies (Biolegend,
San Diego, CA).
Bacterial phagocytosis and killing activity of neutrophils
For assessing KPn phagocytosis, peritoneal neutrophils were isolated by previously
described method [125] and were incubated with GFP-labeled KPn (kindly provided by
Dr. Steven Clegg, University of Iowa) at MOI of 50 with or without opsonization in 10%
normal mouse serum. After 1 hour, the cells were washed twice with ice-cold PBS
followed by two washes with FACS-buffer (PBS+10% fetal bovine serum). The %
positive cells containing fluorescent bacteria were determined by flow-cytometry using
BD LSR II (Becton Dickinson Immunocytometry, San Jose, CA.). For bacterial killing
activity, intracellular CFUs in Clec4d-/- and WT neutrophils were enumerated at 1h and
3hp.i. by gentamycin protection assay as described previously [126].
Statistics
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test;
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose,
CA).
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RESULTS AND DISCUSSION
In order to investigate the role of Clec4d in KPn pneumonia, we first examined if the
Clec4d-/- and WT mice respond to pulmonary KPn infection differentially. For this we
initially infected the mice intranasally with a lethal dose of 1x105 CFUs (determined
experimentally). One hundred percent of the WT mice died within 5 dp.i. at this dose
while all the Clec4d-/- mice reproducibly succumbed to infection 1-2 days earlier than the
WT mice (data not shown). In order to finalize a dose at which the WT mice would
display minimal morbidity and mortality while the Clec4d-/- mice would all succumb to
infection, mice were infected with sublethal dose of 5x104 CFUs. As shown in Fig. 9A,
70-80% of WT mice infected with 5x104 CFUs of KPn survived the infection with
transient signs of disease (ruffled fur, lethargy) early during infection and appeared
healthy later. The Clec4d-/- mice, in contrast, were extremely susceptible to this dose.
Majority of these mice died within 5dp.i. and 100% of mice succumbed to infection by
day 7 with progressive development of disease and overt signs of infection (piloerection,
hunched gait, lethargy, increased respiratory rate). Importantly while the disease signs
appeared at similar times (2dp.i.) in WT and Clec4d-/- mice, they became divergent by
3dp.i. While the WT mice appeared to enter recovery phase at that time, the Clec4d -/mice continued to display disease progression. The recovery phase of WT mice strongly
correlated with the expression level of Clec4d in their lungs where Clec4d mRNA was
maximally transcribed by 3dp.i. (Fig. 9B). This was followed by a downregulation in
Clec4d transcript that was reduced to only marginal levels by 5dp.i. These results
indicated a protective role of this receptor in the resolution of KPn pneumonia.
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Next, serial dilutions of homogenized lungs, liver and blood from infected Clec4d-/- and
WT mice were plated on LB. For initial 2 days, the Clec4d-/- and WT animals displayed
similar bacterial burdens in their lungs (Fig. 9C). Overwhelming loads were detected in
lungs of Clec4d-/- mice at 3dp.i. which remained high at 5dp.i., the time when majority of
mice had become moribund. In contrast, the WT mice displayed 3-5 logs lower bacterial
burden at 3dp.i. and the counts continued to drop through 5dp.i., indicating a resolution
of the infection in these mice. The Clec4d-/- mice also displayed higher and earlier
systemic dissemination of bacteria as depicted by significantly higher bacterial load in
liver even at 2dp.i. and a more severe bacteremia (Fig. 9C). In contrast, no viable bacteria
were detected in the blood of WT mice by 5dp.i. These data indicated that Clec4d
mediated responses directly or indirectly influenced bacterial clearance in pneumonic
infection with KPn.
To examine if the inability of Clec4d-/- mice to clear bacteria was due to a defect in
mounting inflammatory response, pro-inflammatory cytokines in infected mice lungs
were analyzed. In both strains, mock infected mouse lungs displayed similar low basal
levels of inflammatory cytokines tested (TNF-α, IFN-γ, IL-6, IL-17) (Fig. 10A). Upon
KPn infection, WT mice exhibited increased levels of these cytokines at 1dp.i., which
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Figure 9. Clec4d-/- mice display increased mortality accompanied with
overwhelming bacterial burden in systemic organs during Gram negative
pneumonia.
(A). Sixteen WT (C57BL/6) and seventeen Clec4d-/- mice were intranasally infected with
5X104 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile PBS and were assessed
daily for disease severity. The increased susceptibility of Clec4d -/- mice as compared to
WT mice is statistically significant as determined by Kaplan-Meier survival curve
statistical analysis (p<0.001). (B) Total RNA was extracted by Trizol method from lungs
harvested at the indicated times after infection with 5X104 CFUs of KPn. The mRNA
levels of Clec4d were analyzed by real-time PCR as described in Materials and Methods
and are expressed as fold changes over the levels in mock control mice calculated by
using the formula 2−(ΔΔCt). Data shown are the averages of 6-8 mice per group in two
independent experiments. (C). WT and Clec4d-/- were intranasally infected with 5X104
CFUs of KPn. At indicated times post infection the mice were sacrificed, systemic organs
were isolated, homogenized and plated as described in Materials and Methods. Bacterial
burden was enumerated after incubating the plates overnight at 37oC. The data shown is
from one representative experiment (5 animals at each time point) out of three performed with
similar results. Significant differences in bacterial burden (using non-parametric Mann-

Whitney test) in WT and Clec4d-/- are denoted by asterisks (*, p<0.05; **, p<0.005,
***p<0.001).

55

56

started to drop by 3dp.i. and were reduced to minimumby 5dp.i. (Fig. 10A). This was
consistent with the reduced bacterial burden in these mice at these times post-infection.
In contrast, infection of Clec4d-/- mice resulted in a progressive increase in levels of these
cytokines through the course of infection, showing a massive upregulation at 3d and
5dp.i. Interestingly, at 1dp.i., the levels of these cytokines were slightly lower than those
in the WT mice at that time p.i., however the differences were not statistically significant.
Of note, unlike the pro-inflammatory cytokines tested, the amount of IL-10, a regulatory
cytokine was significantly reduced at 5dp.i. in comparison to its level at 3dp.i. in Clec4d/-

miceThis was in contrast to other cytokines and chemokines whose levels continued to

increase or stayed at similar high levels through day 5p.i. in these mice. In light of a
recent study implicating STAT-1 regulated IL-10 production in resolution of KPn
pneumonia [127], reduced level of this cytokine, either due to depletion of IL-10
producing cells in Clec4d-/- mice or due to the role of this receptor in continuous
production of this cytokine in a positive feedback loop manner, possibly plays a role in
lack of resolution in these mice. Notwithstanding the mechanism, our results show that
Clec4d-/- mice do not display a defect in their ability to mount an inflammatory response
but rather display a hyperinflammatory phenotype akin of cytokine storm typically
associated with sepsis. Moreover, levels of sepsis marker mediators such as Factor VII,
C-reactive protein and fibrinogen were also massively increased in these mice (data not
shown). Importantly, in the absence of Clec4d, these mice are unable to resolve the
infection and the resulting inflammation. This further indicates a protective role of this
receptor in resolution of KPn pneumonia.
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Next, H&E staining was performed to determine immunopathological changes in WT and
Clec4d-/- mice. As shown in Fig. 10B, mock control WT and Clec4d-/- mice display
similar normal lung tissue morphology. A moderate peribronchial and perivascular
infiltration of immune cells was observed in WT mice, which was reduced substantially
by 5dp.i. The overall architecture of the lungs was largely preserved in the WT animals
throughout the infection. The Clec4d-/- mice, on the other hand, displayed a moderate
immune cell infiltration for initial 2 days after infection. However, at later time points
these mice exhibited much more severe pathological changes in their lungs with
progressive increase in leukocytes (mainly neutrophils, as depicted by multilobed nuclear
morphology in high magnification inset) infiltration through 3dp.i. By day 5 p.i., a time
when the mice had become moribund, extensive foci of consolidation were visible with
massive accumulation of neutrophils around alveolar spaces. Flow cytometry analysis of
infiltrating cells in lungs showed that the numbers of Ly6G+CD11b+ neutrophils were
significantly higher in the Clec4d-/- lungs at 3dp.i. in comparison with the WT (Fig. 10C).
Interestingly, the Clec4d-/- mice showed a significantly increased number of neutrophils
even at 2 p.i., a time when the bacterial burden was similar in the Clec4d-/- and WT lungs.
In order to further determine if these neutrophils were defective in bacterial clearance in
the absence of Clec4d, phagocytosis of GFP-labeled KPn was compared between WT
and Clec4d-/- neutrophils by flow cytometry (as described in methods). As shown in Fig.
11A, Clec4d deficiency had no effect on phagocytosis of opsonized or non-opsonized
bacteria. Furthermore, these neutrophils showed a similar bacterial killing ability as their
WT counterparts (Fig. 11B). This indicated that Clec4d likely does not play a direct role
in bacterial clearence and the increased neutrophil accumulation in pneumonic Clec4d-/-
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Figure 10. Pneumonic Clec4d-/- mice exhibit hyperinflammatory response and severe
lung pathology characterized by massive neutrophil accumulation.
(A). The lungs from mock control and KPn infected WT and Clec4d-/- mice were
harvested at indicated time points post-infection, homogenized in PBS with protease
inhibitors and analyzed for rodent multi-analyte profile (MyriadTM Rules-Based
Medicine, Austin, TX). Results shown are average of three infected and three mock
control mice from 3 independent experiments. Significant differences are denoted by
asterisks (*, p<0.05; **, p<0.005, ***p<0.001). (B). H&E staining of lung cryosections
from mock control and KPn infected WT and Clec4d-/- mice isolated at indicated times
post-infection. Magnification 100X. Inset shows a highly magnified area (1000X) of a
lesion in infected Clec4d-/- depicting neutrophils as indicated by characteristic multilobed
nuclear morphology. (C). Flow cytometry analysis of neutrophils in mock control (WTM and Clec4d-/--M) and KPn infected (WT-Inf and Clec4d-/--Inf) WT and Clec4d-/- mice.
Total lungs cells were isolated from mice by collagenase treatment at indicated times p.i..
The cells were stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as
markers for neutrophils. Appropriate isotype matched negative controls were used to set
the gates. The bar graph shows average of total number of neutrophils in lungs of three
mock control and three KPn infected WT and Clec4d-/- mice from 3 independent
experiments (total 9 mice per group). Dot plots shown on the right are representative of
three mice per group in 3 independent experiments. Statistical significance between WT
and

Clec4d-/-

mice

are

denoted
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by

asterisks

(**,

p<0.005).
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Figure 11. Clec4d deficiency does not impair neutrophil phagocytosis and killing of
bacteria but leads to their unbridled accumulation and activation.
(A). Peritoneal neutrophils from WT and Clec4d-/- mice were incubated with GFP
(Green Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized)
10% normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow
cytometry. The results are expressed as % cells positive for fluorescent bacteria. (B).
Bacterial uptake and killing capacity of Clec4d-/- and WT neutrophils was determined at
1h and 3h by assessing intracellular CFUs in these cells as described in Methods. The
experiment was repeated 3 times with similar results.

(C).

The lungs from mock control

and KPn infected WT and Clec4d-/- mice were harvested at indicated time points postinfection, homogenized in PBS with protease inhibitors and analyzed commercially for
neutrophil associated immune mediators using rodent multi-analyte profile (MyriadTM
Rules-Based Medicine, Austin, TX). Results shown are average of three infected and
three mock control mice from 3 independent experiments. Significant differences are
denoted by asterisks (*, p<0.05; **, p<0.005, ***p<0.001).
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mice is not a secondary effect resulting from a defective bacterial clearance in the
absence of this CLR. On the other hand, neutrophil chemoattractants (CXCL1 and
CXCL6), neutrophil survival mediator (GM-CSF) and neutrophil activation markers
(MMP9, MPO) were significantly higher in Clec4d-/- mice, as compared to their WT
counterparts (Fig. 11C). These results show that Clec4d is likely involved in neutrophil
turnover and the absence of Clec4d results in greater and prolonged accumulation of
neutrophils in lungs of mice. The persistent activation of these neutrophils is leading to
greater lung pathology observed in Clec4-/- mice as compared to their WT counterparts
where the neutrophils infiltrate transiently and are cleared off as the infection resolves.
These observations clearly suggest that while deficiency of Clec4d does not impair
infiltration, bacterial phagocytosis and activation of neutrophils, this CLR is required for
resolution of inflammation by way of facilitating neutrophil turnover.
Resolution of inflammation is an active and tightly controlled process which is necessary
for restoration and maintenance of tissue homeostasis. Deregulation of this process is the
root cause of many diseases. Our results indicate that deficiency of Clec4d in an
otherwise

sublethal

pulmonary

KPn

infection

leads

to

a

non-resolving,

hyperinflammatory response which culminates in the death of infected KO animals. This
report, for the first time shows that Clec4d likely plays a role in resolution of
inflammatory response. Neutrophil mediated responses are essential for combating
pneumonic bacterial infection and their protective role in sepsis and KPn infection in
particular has been described elegantly [126,128]. However, persistent accumulation of
neutrophils can lead to bystander tissue destruction, owing to their tissue destructive
cargo. Accumulation of large numbers of neutrophils in the lungs of KO mice and higher
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amounts of their associated inflammatory mediators suggests that there is a defect in
neutrophil turnover in these mice. Since Clec4d was found not to be directly involved in
bacterial uptake and killing by neutrophils, it seems more likely that due to the widespread tissue damage owing to persistent neutrophil activity in the Clec4d-/- mice, other
immune cells important for bacterial clearance are depleted leading to this increase in
local bacterial burden as well a systemic spread. Thus an increased bacterial burden
(secondary to the defect in neutrophil turnover) is likely a factor contributing to the
increased mortality of these mice eventually. As the neutrophil turnover and resolution of
neutrophil associated responses is a complex process involving apoptosis and clearance
of their contents (efferocytosis) and class-switching of lipid mediators, we are currently
investigating the role of Clec4d in these processes.
This study shows that Clec4d plays an important role in mitigating the inflammation
during a pneumonic infection, possibly by facilitating neutrophil turnover. This study
opens up new avenues of research on the role of Clec4d in resolution of inflammatory
responses. This can have major implications in the therapeutic measurements of
inflammation associated disorders.
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Abstract
Sepsis

is

a

complex

immune

disorder

that

is

characterized

by

systemic

hyperinflammation. Alarmins, which are multifunctional endogenous factors, have been
implicated in exacerbation of inflammation in many immune disorders including sepsis.
Here we show that Galectin-9, a host endogenous β-galactoside binding lectin, functions
as an alarmin capable of mediating inflammatory response during sepsis resulting from
pulmonary infection with Francisella novicida, a Gram negative bacterial pathogen. Our
results show that this galectin is upregulated and is likely released during tissue damage
in the lungs of F. novicida infected septic mice. In vitro, purified recombinant galectin-9
exacerbated F. novicida-induced production of the inflammatory mediators by
macrophages and neutrophils. Concomitantly, Galectin-9 deficient (Gal-9-/-) mice
exhibited improved lung pathology, reduced cell death and reduced leukocyte infiltration,
particularly neutrophils, in their lungs. This positively correlated with overall improved
survival of F. novicida infected Gal-9-/- mice as compared to their wild-type counterparts.
Collectively, these findings suggest that galectin-9 functions as a novel alarmin by
augmenting the inflammatory response in sepsis development during pulmonary F.
novicida infection.
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Introduction
Systemic hyperinflammation is the underlying cause of many immune inflammatory
diseases, including sepsis. Despite more than three decades of active research, severe
sepsis and septic shock remain major healthcare challenges with a mortality rate of 2050% and no effective therapy [5]. During sepsis, overwhelming and sustained release of
pro- as well as anti-inflammatory cytokines, termed cytokine storm, causes extensive
tissue damage and wide-spread cell death, eventually resulting in death. Despite the
identification of cytokine circuitry as major determinants of mortality, pro-inflammatory
cytokine blockade has been ineffective as therapy for sepsis. This indicates the
involvement of additional mediators that are likely acting as regulators and/or
perpetuators of this hyper inflammatory response.
Alarmins are evolutionarily conserved endogenous molecules that perform homeostatic
functions when contained within cellular compartments [29]. However, under
pathological conditions, these molecules can be released either passively from dead cells
or actively via non-classical secretion pathways [84]. Once in the extracellular milieu,
they exhibit immune modulatory properties such as induction of pro-inflammatory
cytokines, immune cell chemotaxis, and regulation of cell death [29]. In fact, a sustained
and excessive release of alarmins has been shown to contribute to pathogenesis of several
sterile as well as infectious inflammatory conditions [129,130]. Pertaining to their ability
to impact innate immune cells such as macrophages, dendritic cells and neutrophils,
alarmins also represent a crucial link between innate and adaptive immune responses, and
hence an attractive therapeutic target for complex disorders such as sepsis.
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Francisella is a highly virulent bacterial pathogen that causes an acute lethal disease
called tularemia in humans and mice. Although there are strain-dependent differences in
the initial mechanisms involved [131,132], our studies have shown that pulmonary
infection of mice with fully virulent Francisella tularensis as well as the murine model
organism F. novicida (F.n.) leads to development of severe sepsis characterized by
hyperinflammation, T cell depletion, and extensive cell death in systemic organs
[73,77,78]. As pulmonary infections are a major cause of sepsis [76], we are using a
murine inhalation model of F.n. infection to understand the mechanism/s responsible for
pulmonary infection-induced sepsis development. A recent report of an F.n. outbreak in a
correctional facility suggests that this strain may be more virulent to humans than initially
surmised, supporting its relevance as a model strain to understand pathogenesis [133].
Furthermore, studies from our and other laboratories have shown that extensive tissue
damage and wide-spread cell death is a hallmark of Francisella infection, regardless of
the bacterial strain [78,80,81]. Additionally, our studies show that Francisella infected
macrophages are defective in clearance of dead cells, a process termed efferocytosis,
leading to accumulation of these dead cells and their progression to secondary necrosis
[74]. It is thus likely that alarmins released from these dead or dying cells contribute to
the inflammatory response culminating in sepsis development during respiratory
infection with Francisella. We and others have reported an alarmin-mediated regulation
of the inflammatory response during pulmonary infections [1,134,135].

However, in a

complex immune disorder like sepsis which is an interplay of several host immune
pathways such as the coagulation system, complement cascade and even the autonomic
nervous system [26], several alarmins may be involved at the intersections of these

69

pathways. Thus, identification of additional alarmins will present therapeutic targets that
may have more tangible translational potential when used in combination.
Galectins, mammalian β-galactoside binding lectins, are emerging as potent immune
regulators in a variety of pathological processes including inflammation, autoimmunity,
fibrosis, and cancer [88,121]. Curiously, some galectins (galectin-1 and -3) have been
shown to be secreted in the extracellular milieu via a non-classical ER/Golgi-independent
pathway, where they exert immune modulating effects on immune cells. This is a
characteristic feature of alarmins [136,137]. However the contribution of galectins as
alarmins to sepsis development is poorly understood. In this study we have investigated
the role of galectin-9, in the F.n. induced inflammatory response and sepsis. Our analyses
of galectin-9 expression, distribution, immune modulation and comparison of disease
progression in F.n. infected galectin-9 sufficient and –deficient mice show that galectin-9
acts as an alarmin to exacerbate the inflammatory response in Francisella infection
induced sepsis development.

Materials and Methods
Ethics Statement
The animal usage protocols were approved by the Institutional Animal Care and Usage
Committee at the University of North Dakota (protocol no. 1108-3). All procedures
strictly followed the institutional and federal guidelines and all efforts were made to
minimize the animal suffering.
Bacterial strains and Mice
The F.n. strain U112 was grown on Trypticase Soy Agar (TSA) medium supplemented
with L-cysteine at 37oC. After overnight growth, the bacteria were harvested and
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suspended in a freezing medium (250 mM sucrose, 10 mM sodium phosphate pH 7.2 and
5 mM glutamic acid). Aliquots of the stocks were frozen at -80oC for further use. The
animal usage protocols were approved by the Institutional Animal Care and Usage
Committee at the University of North Dakota. All procedures strictly followed the
institutional and federal guidelines and all efforts were made to minimize animal
suffering. In vivo experiments were performed using 6-8 wk old female C57Bl/6 wildtype and Gal-9

-/-

mice. Gal-9

-/-

mice were kindly provided by Dr. Judy M. Teale,

University of Texas at San Antonio (initially obtained from the Consortium of Functional
Glycomics, Scripps, La Jolla) as F4 and were back-crossed for additional 6 generations.
Sex- and age-matched Gal-9+/+ mice with the same genetic background were used as
controls.
Antibodies and Reagents
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For
detection of galectin-9 by immunofluorescence (IF) staining, a purified rat galectin-9
antibody (Abcam, San Diego, CA) followed by Alexa-546 conjugated chicken anti-rat
antibody (Molecular Probes, OR) was used.

A rat anti-mouse CD11b antibody

conjugated to PE (BD Pharmingen) and a purified rat anti-mouse Ly-6G (Clone Accurate
Chemical, Westbury, NY, USA) followed by chicken anti-rat Alexa488 (Molecular
Probes, OR) were used for detection of activated neutrophils by IF staining. For flow
cytometry Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G (Clone 1A8)
antibodies (Biolegend, San Diego, CA) were used. The terminal deoxyribonucleotidyl
transferase-mediated triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining kit
was purchased from Chemicon International, CA. Purified recombinant galectin-9 was
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purchased from R&D Systems, MN. The endotoxin level was <1.0 EU per µg of protein.
Ultrapure E. coli endotoxin was purchased from Invivogen and lactose was purchased
from Sigma. For detection of reactive oxygen species, Fc OxyBURST assay reagent was
purchased from Molecular Probes, Eugene, OR. Mouse IL-6 ELISA kits (BD OptEIA)
were from BD Biosciences, San Diego, CA.
Infection of Mice, survival and bacterial burden
Mice were anaesthetized using a mixture of ketamine HCL and xylazine (30mg/ml
ketamine, 4 mg/ml xylazine in PBS) and were infected intranasally with 50-70 CFUs of
the F.n. strain U112 in 20 μl of PBS or with 20 µl of PBS alone. The mice were
monitored daily. The survival of infected mice (15 mice each WT and Gal-9-/- in 3
independent experiments) was recorded for up to 2 weeks post-infection (p.i.). The death
was recorded as tularemia induced mortality. Mice displaying severe signs of distress
(labored breathing, non-responsiveness to cage tapping, failure of grooming and severe
eye discharge) were humanely sacrificed by injecting a mixture of ketamine (90120mg/kg) and xylazine (10mg/kg) followed by cervical dislocation. In some
experiments, the mice were euthanized at indicated times p.i. and blood, lungs, liver and
spleen were aseptically harvested. The organs were homogenized aseptically in cold PBS
with CompleteTM protease inhibitor cocktail (Roche Diagnostics, Germany). For the
bacterial burden analyses, the homogenates and blood were serially diluted in PBS and
plated on TSA. CFU counts per mouse were calculated after incubating the plates at 37 oC
overnight.
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Quantitative real-time PCR
Lungs from infected and mock control mice at various times p.i. were removed
immediately after perfusion and total RNA was extracted using Trizol reagent
(Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis of the
samples was performed using SYBR green (Applied Biosystems, CA, USA) as described
by us [1]. Transcript levels of the housekeeping ribosomal 18S and galectin-9 genes were
measured in each sample by PCR amplification using specific primers: 18S (forward) 5'CATGTGGTGTTGAGGAAAGCA-3'
GTCGTGGGTTCTGCATGATG-3';

and

(reverse)

5'-

Gal-9

(forward)

5'-

and

TCAAGGTGATGGTGAACAAGAAA-3’

(reverse)

5’-

GATGGTGTCCACGAGGTGGTA -3’. The target gene expression levels were
normalized to those of the house keeping 18S gene in the same sample. Expression of
galectin-9 in infected samples was determined as fold change over that in control samples
calculated by using the formula 2−(ΔΔCt).
Histological and Immunofluorescence staining
For histological and immunofluorescence staining, frozen lung tissues were processed as
previously described [77]. Lung cryosections thus obtained were stained with
hematoxylin and eosin (H&E) for pathological analysis, or for the detection of galectin-9
by immunofluorescence staining, as previously described [89]. Semi-quantitative
histopathology was performed as described previously in [138]. For the detection of cell
death, TUNEL method was used according to manufacturer’s instructions (Chemicon
International, CA). The images were acquired using a Nikon Eclipse fluorescent
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microscope with an attached SPOT II digital camera. The images were processed and
analyzed using Adobe Photoshop 7.0 software (Adobe, Mountain view, CA).
Flow cytometry
Lungs were harvested from the infected and mock control mice at 3 days p.i. (dpi) after
perfusion with PBS and were treated with collagenase to obtain single cell suspensions as
previously described [77,78]. Cells were then co-stained with anti-CD11b and -Ly6G
antibodies. FlowJo (Tree Star) software was used to analyze data.
Multi-analyte profile analysis
The lung homogenates were prepared as described for the bacterial burden analysis above
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants
were immediately frozen at -80o C. The biomarker levels in lung homogenates were
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing
a multiplexed flow-based system: Mouse MAPTM (Multi-Analyte Profiles) analysis
technology.
Neutrophil and macrophage activation
Cells were isolated from the peritoneal cavities of naïve C57BL/6 mice 12-14h after
intraperitoneal injection of sterile 4% thioglycollate. Non-adherent neutrophils were
plated at the density of 1x106 cells and were infected with wild-type F.n. strain U112 at
MOI 50 with or without pretreatment of the cells with 15µg/ml of purified recombinant
galectin-9. Cells stimulated with galectin-9 alone or with 10ng/ml of phorbol myristate
acetate (PMA) served as controls. One hour after stimulation, production of reactive
oxygen species (ROS) was measured in the cells by flow cytometry using Fc OxyBURST
reagent according to the manufacturer’s instructions. A minimum of 20,000 events were
read for each sample and all the cells fluorescing positive in FITC channel (excitation and
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emission maxima of ~490 nm and ~520 nm, respectively) were gated to obtain the
percentage of ROS producing cells.
Bone marrow was isolated from wild-type and Gal-9-/- mice and the cells were
differentiated to macrophages as previously described [91]. On day 6 of culture, the cells
were plated at 8×104 cells / well in 96-well flat-bottom plates and were stimulated with
galectin-9 with or without 25mM lactose. As a control for endotoxin contamination,
recombinant galectin-9 or UltraPure LPS boiled for 45 min at 100 °C were used to
stimulate cells. Culture supernatants were collected 24h after stimulation and IL-6 levels
were measured by ELISA according to the manufacturer’s instructions (BD OptEIA, BD
Biosciences).
Statistical Analysis
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test;
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses
were performed using two-way ANOVA with Tukey post-test.
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Results
Galectin-9 is upregulated and released during the septic phase of F.n. infection.
We and others have previously shown that extensive cell death is a hallmark of
pulmonary Francisella infection, regardless of the bacterial strain used (8, 9, 21-23).
Factors released from dead or dying cells, termed as alarmins, have been shown to exhibit
inflammatory, chemoattractant and immune activating properties in various pathological
conditions. To test our hypothesis that galectin-9 functions as an alarmin, we first
analyzed the expression and distribution of galectin-9 in the lungs of mice undergoing
pulmonary infection with F.n. As shown in Figure 12A, galectin-9 transcript levels
progressively increased in the lungs of infected mice and reached the highest levels at
3dpi. This increase in galectin-9 expression at 3 dpi is consistent with the appearance of
other sepsis features (extensive cell death, hyperinflammatory response, increased
vascular injury) at this time, as reported in our previous studies with F.n. as well as the
fully virulent F. tularensis [77,78]. Immunofluorescence (IF) analysis of galectin-9
protein expression in cryosections of the lungs harvested at this septic phase showed a
low basal level of galectin-9 in mock control mice inoculated with PBS alone (Fig. 12.B).
F.n. infected mice, on the other hand, exhibited very high galectin-9 expression in their
lungs. Furthermore, galectin-9 could be detected in cell-free areas, especially in the
lesions with massive cellular infiltration, indicating that it is likely released
extracellularly (Fig. 12.B lower panel and inset). Together, these data suggested that
galectin-9 likely exhibits a characteristic alarmin property of extracellular release during
septic phase of pulmonary F.n. infection.
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Figure 12. Galectin-9 is upregulated and released in lungs of mice during
respiratory F. novicida (F.n.) infection.

(A) Total RNA was extracted by Trizol method from lungs harvested at the indicated
times after infection with the F.n. strain U112. The mRNA levels of galectin-9 were
analyzed by real-time PCR as described in Materials and Methods and are expressed as
fold increase over the levels in mock control mice. Data shown are the averages of 3- 4
mice per group. (B) In-situ IF staining of frozen lung sections from mock control and
U112 infected mice harvested at 3 dpi. The sections were stained for galectin-9 (red)
using a purified rat galectin-9 antibody followed by Alexa-546 conjugated chicken antirat antibody. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindol-dilactate
(DAPI). Magnification X 200. Inset depicts possible extracellular galectin-9 in infected
mouse lungs. The area indicated by green arrow has been enlarged and shown in (C).
Asterisks depict galectin-9 present in cell-free areas.
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Galectin-9 deficiency ameliorates lung pathology in F.n. infected mice
In order to assess the role of galectin-9 in overall disease severity during tularemia, we
next examined H&E stained lung cryosections from F.n. infected wild-type (WT) and
Gal-9-/- mice. Consistent with our previous studies, a progressive increase in cellular
infiltration was observed in the F.n. infected WT mice with extensive pathology, severe
bronchopneumonia and massive cell death, occurring in the center of large granulomalike areas of infiltration at 3 dpi (Fig. 13.A upper panel). The lungs of Gal-9-/- mice, on
the other hand, showed a substantial delay in the cellular infiltration with moderate
peribronchial and perivascular infiltration by 3dpi (Fig. 13.A lower panel). Although
these mice displayed an increased cellular infiltration at 5dpi, the lesions appeared much
smaller in the lungs of Gal-9-/- mice as compared to those in the WT mice.
Concomitantly, the Gal-9-/- mice exhibited significantly lower pathological score in
comparison with their WT counterparts at all the time points tested (Fig. 13.B). Mock
infected WT and Gal-9-/- mice exhibited similar normal lung architecture with minimal
cellular infiltration and clear air spaces (data not shown). As alarmins are released
passively from dead cells, we analyzed the extent of cell death in the lungs of infected
WT and Gal-9-/- mice by TUNEL assay. As shown in Figure 13C, septic lungs of F.n.
infected WT mice showed extensive cell death, indicated by a large number of TUNEL
positive cells within perivascular and peribronchial lesions. In contrast, infected Gal-9-/mice exhibited significantly fewer TUNEL positive cells in their lungs (Fig. 13.C). The
improved lung architecture and reduced cell death in the absence of galectin-9 indicates a
pathological role of this lectin during pulmonary Francisella infection.
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Figure 13. Gal-9-/- mice exhibit improved lung pathology and reduced TUNEL
staining indicative of cell death upon pulmonary F.n. infection.

(A) The lungs from F.n. infected wild-type (WT) or Gal-9-/- mice were harvested at
indicated times post-infection, embedded in optimal-cutting-temperature (OCT)
compound, and sectioned as described in Materials and Methods. The frozen sections
were stained with Hematoxylin and Eosin (H&E). The images obtained are
representatives of three experiments performed with 3 mice per group in each
experiment. Magnification, ×200. (B) H&E sections were scored in blinded fashion
according to the following scoring scale: 0, no inflammatory cells (macrophages or
neutrophils) present in section; 1, <5% of section infiltrated by inflammatory cells; 2, 5–
10% of section infiltrated; 3, 20% of section infiltrate; and 4, >20% of section infiltrated.

(C) Frozen lung sections from F.n. infected WT or Gal-9-/- mice were processed for insitu TUNEL staining for detection of DNA fragmentation (red) in nuclei. Nuclei (blue)
were stained with 4′,6′-diamidino-2-phenylindole dilactate. Bar graph shows Mean
fluorescence intensity (MFI) quantified using Image J software. Magnification, ×100.
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Galectin-9 regulates cellular infiltration and inflammatory response in vivo during F.n.
infection
Alarmins exert their immune stimulatory effects by mediating immune cell infiltration
directly or indirectly, and by predisposing the cells to produce increased levels of
inflammatory mediators in response to infection. We hypothesized that; similar to the
function of alarmins, increased expression and extracellular localization of galectin-9
may be contributing directly or indirectly to the increased cellular infiltration and
hyperinflammatory response observed during pulmonary Francisella infection. Previous
studies from our and other laboratories have shown that neutrophils are the predominant
cell type infiltrating in F.n. infected WT mice [77,78,94,139]. In order to compare
neutrophil infiltration in the lungs of Gal-9-/- and WT mice infected with F.n., IF staining
and flow cytometry was performed. Consistent with our previous studies, lungs of the
infected WT mice showed extensive infiltration of CD11b+ Ly6G+ neutrophils that
accumulated largely in the lesions (Fig.14.A and B). The numbers of Ly6G+CD11b+
cells in Gal-9-/- mice, on the other hand, were significantly reduced (Fig.14.A and B).
These results suggested a role of galectin-9 in regulation of neutrophil accumulation in
the lungs of mice during pulmonary F.n. infection. Furthermore, analysis of the levels of
inflammatory cytokines and neutrophil-associated mediators in the lungs revealed
significantly reduced levels of TNF-α, IL-6, myeloperoxidase (MPO), matrix
metalloproteinase-9 (MMP-9) and GM-CSF, in the infected Gal-9-/- mice (Fig.14.C).
Together, these results suggested a putative role of galectin-9 in neutrophil accumulation
and associated inflammation.
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Figure 14. Gal-9-/- mice display reduced accumulation of neutrophils and reduced
inflammatory mediators in lungs during F.n. infection.

(A) Frozen sections of lungs harvested at 3 dpi from F.n. infected WT or Gal-9-/- mice
were co-stained with antibodies against myeloid cell markers CD11b (red) and Ly6G
(green). A high co-expression of both markers is depicted by yellow color and indicates
neutrophils. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindol-dilactate
(DAPI). Magnification X 200. Asterisks depict lesions in the lungs. (B) Flow cytometry
analysis of neutrophils in mock control and F.n. infected WT and Gal-9-/- (WT-Fn and
Gal-9-/--Fn) mice. Total lungs cells were isolated from mice by collagenase treatment at 3
dpi as described in Methods. The cells were stained with anti-Ly6G-APC and antiCD11b-Pacific Blue antibodies as markers for neutrophils. The plots are representative of
three mice per group in 3 independent experiments. (C) Lungs from mock infected and
F.n. infected WT or Gal-9-/- mice were harvested at 3dpi, homogenized with protease
inhibitors in PBS and analyzed commercially for rodent multi-analyte profiles (Myriad
Rules-Based Medicine, Austin, TX). Levels of inflammatory cytokines and neutrophil
markers in lung homogenates are shown. Results shown are from 3-4 mice per group
from

3

different

experiments.

MMP-9;

matrix

metalloproteinase

9,

MPO;

myeloperoxidase. * p<0.05; ** p<0.005; *** p<0.001. Comparisons were made between
infected WT and Gal-9-/- groups.
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Galectin-9 exacerbates F.n. infection induced inflammatory response in vitro
To examine the direct effect of galectin-9 on activation of neutrophils and macrophages,
two cell types playing a predominant role in tularemia pathogenesis, we next carried out
in vitro stimulation of these cells with recombinant galectin-9 protein with or without F.n.
infection. While stimulation with purified galectin-9 or U112 infection alone moderately
induced ROS production in peritoneal neutrophils, pre-treatment of neutrophils with this
lectin induced an increased amount of ROS in response to F.n. infection, which was
significantly higher than that elicited by galectin-9 or F.n. infection alone (Fig.15.A).
Stimulation of bone marrow derived macrophages (BMDMs) with galectin-9 alone or
galectin-9 and U112 together elicited a significantly higher IL-6 production than U112
alone. (Fig. 15.B). This immune stimulatory effect of galectin-9 was abolished upon
heat-denaturation or by addition of 25mM lactose to the cultures, confirming the
specificity of this activity. These observations indicated that while galectin-9 by itself can
stimulates myeloid cells, particularly macrophages, it can also augment Francisella
infection-induced myeloid cell activation which likely has implications in exacerbation of
inflammation culminating in sepsis development during this infection.
Gal9-/- mice show improved survival following F.n. infection.
In order to correlate the improved lung pathology and reduced inflammatory responses
with the disease outcome, overall disease severity and survival was compared in WT and
Gal-9-/- mice infected with F.n. In the infected WT mice, visible signs of disease started
to appear by 3 dpi which typically included piloerection, hunched gait, lethargy, and eye
discharge. All of these mice succumbed to infection by day 6 p.i. (Fig. 16.A). By contrast
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Figure 15. Galectin-9 regulates F.n. infection induced inflammatory response in
vitro.

(A). Peritoneal neutrophils were isolated from mice 12-14h after injection with 4%
thioglycollate and were stimulated with F.n. at an MOI 50 with or without pre-treatment
with purified recombinant galectin-9 (15µg/ml). Stimulation with galectin-9 alone or
phorbol myristate acetate (PMA, 10ng/ml) was used as a control. Production of reactive
oxygen species (ROS) was measured one hour post-stimulation by flow-cytometry using
Fc-OxyBURST dye following the manufacturer’s instructions. Numbers below the plots
depict average percent of ROS positive cells from 3 independent experiments. Plots from
a representative of these 3 independent experiments are shown. (B) Bone marrow
derived macrophages (BMDMs) from C57Bl/6 wild-type mice were stimulated with F.n.
Strain U112 at an MOI of 50 with or without pretreatment with 15µg/ml of purified
recombinant galectin-9. UltraPure E.coli LPS (10ng/ml) and galectin-9 with and without
heat-denaturation (boiled at 100oC for 45 min) as well as competitive inhibition with
lactose (25mM) were used as controls to test the specificity of galectin-9 effect, as
described in methods. Culture supernatants were collected 24h after infection and the
amount of IL-6 was measured by ELISA. The data shown is average of three independent
experiments. Statistical analysis between the data sets was performed by Two-way
ANOVA with Tukey post-test where * p<0.05; ** p<0.005; *** p<0.001.
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Gal-9-/- mice exhibited delayed appearance of disease symptoms and showed
significantly improved survival as compared to the infected wild-type mice (Fig.16.A).
The improved survival of Gal-9-/- mice, however, did not correlate with bacterial burdens
in their lungs, spleen and liver since similar bacterial load was observed in WT and KO
mice (Fig. 16.B). Intriguingly, Gal-9-/- mice exhibited significantly lower bacterial counts
in their blood at 2dpi than their WT counterparts at that time point indicating a delayed
development of bacteremia in the absence of galectin-9. However, the bacterial burden in
blood was similar in infected WT and Gal-9-/- mice at later time points indicating that
once hematogenous, bacteria replicated at similar rates in both strains.

Discussion
In this study we examined the role of galectin-9, a mammalian β-galactoside binding
lectin, in the development of sepsis during pulmonary infection with F. novicida. We
report the upregulation and extracellular release of galectin-9 during F.n. infection and its
ability to amplify Francisella infection-induced inflammatory response as well as
concomitant improved disease severity of Gal-9-/- mice. These functions of galectin-9 are
all consistent with characteristic properties of alarmins that have been described to play a
pathological role in perpetuation of inflammation.
Sepsis is characterized by a complex, systemic inflammatory response to a traumatic or
infectious insult, such as F.n. infection in the current study. Mechanisms of innate
immune activation in sepsis are no longer thought be induced exclusively by components
of pathogen origin (pathogen associated molecular patterns, PAMPs). Alarmins, that are

88

Figure 16. Gal-9-/- mice show improved survival during pulmonary F.n. infection.

(A) Fifteen each C57Bl/6 WT and Gal-9-/- mice in 3 separate experiments (5 mice per
experiment) were inoculated intranasally with F.n and were monitored daily for 2 weeks.
The improved survival of Gal-9-/- mice compared to WT mice was statistically
significant, as determined by Kaplan-Meier log-rank analysis (P value*** = 0.0003). (B)
Bacterial burdens in lungs, blood, spleen and liver harvested from F.n. infected WT and
Gal-9-/- mice at indicated times post-infection. Lung, liver and spleen homogenates
prepared as described in Materials and Methods and blood were serially diluted and
plated on TSA plates to enumerate bacterial burdens. Each symbol on the plots represents
one mouse and data is from 2-3 independent experiments.
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multifunctional host proteins, have been shown to regulate inflammatory response in
many pathological conditions including sepsis, upon their release from dead/dying host
cells [32,33,96]. High Mobility Group Box1 (HMGB-1), S100 family of proteins, and
heat shock proteins are among the most well-characterized alarmins to date [84],
although the list of alarmins has continued to grow over the past decade [140]. Indeed, in
a complex immune disorder like sepsis, it is likely that several alarmins are involved at
the intersections of various pathways. Our current study shows that galectin-9, a host
lectin, plays a pathogenic role as an alarmin to exacerbate the inflammatory response
during pulmonary infection with Francisella and contributes to sepsis development.
Identification of novel alarmins such as galectin-9 may aide in understanding this
complex disorder and may present additional targets for effective therapeutics.
Galectins are ubiquitously expressed β-galactose binding lectins. These constitute the
only soluble mammalian lectins which are either passively released by dying cells or are
actively secreted by inflammatory cells through a non-classical secretory pathway [66].
Although several galectins have been detected in the extracellular milieu [141], the
precise mechanism of their secretion remains to be determined, since they lack a classical
“leader” sequence. Galectins play homeostatic roles in regulation of cell cycle and
apoptosis, phagosome formation, and stabilization of intracellular signaling when
contained in intracellular compartments [63]. Some of these galectins such as galectin-1
and -3 exhibit inflammatory and T cell apoptotic activities upon extracellular release
[64]. Moreover, the extracellular release of some galectins seems to correlate with the
virulence of invading pathogen [65,137] as well as influences immune responses through
chemotaxis and activation of innate immune cells [64,66]. Despite the progress in our
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understanding of the inflammatory properties of galectins, the role of these lectins as
alarmins in the development of sepsis is not defined. Our results described here show, for
the first time that galectin-9, mostly studied for its function as modulator of T cell
immunity, is likely released extracellularly and modulates innate immune responses by
affecting immune cell infiltration and activation during a septic infection by F.n.
Although speculative at this stage, the reduced number of leukocytes in F.n. infected Gal9-/-

mice

suggests

that

this

lectin

directly

or

indirectly

affects

cellular

infiltration/accumulation in sepsis. To the best of our knowledge, there are no reports
examining the impact of galectin-9 on innate cell infiltration during an acute pneumonic
infection although, human galectin-9 has been identified as a potent eosinophil
chemoattarctant with implications in allergic airway inflammation [142]. Galectin-9 has
also been shown to induce IL-8 production by bronchial epithelial cells in cystic fibrosis,
influencing neutrophil infiltration and early neutrophil-dominated inflammation in the
cystic fibrosis lung [143]. Reduced levels of neutrophil chemoattractant and activation
markers in Gal-9-/- mice in our studies suggest that this lectin may exert its effect on
cellular infiltration indirectly by modulating the levels of these chemokines. This
observation is in line with the role of the prototypic alarmin HMGB1 in neutrophil
migration by regulating the levels of chemoattractants such as IL-8 [99]. However it is
also possible that galectin-9 influences neutrophil infiltration directly by binding to its
receptor T cell Ig and mucin domain–containing molecule-3 (TIM-3) which was recently
reported to be expressed by neutrophils [144]. Other proinflammatory alarmins such as
S100 proteins have also been shown to directly promote migration of myeloid cells by
binding to their cell surface receptors [101]. Further studies are needed to test these
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hypotheses. Notwithstanding the mechanism, the reduced neutrophil accumulation in F.n.
infected Gal-9-/- animals indicates a likely chemotactic function of this lectin in F.n.
induced sepsis.
The role of galectin-9 in regulating T helper-1 responses via its interaction with TIM-3
has been extensively studied. Galectin-9 interaction with TIM-3 on T cells results in cell
death causing down regulation of pro-inflammatory Th1 responses implicated in
pathology of autoimmune diseases such as EAE and GVDH [145-147]. However, its role
in myeloid cell activation is much less defined. Recent studies have reported involvement
of TIM-3/galectin-9 interaction in activation of neutrophils and macrophages [144,148].
Another study showed galectin-9 induced secretion of pro-inflammatory cytokines from
monocytes and macrophages, that could amplify immunopathology associated with HCV
infection [149]. Additionally, the effects of galectin-9 on activation and maturation of
antigen presenting cells have been shown [150-152]. More relevant to our study, a recent
study reported that galectin-9 mediates potentiation of TLR-ligation induced TNF-Α and
IL-6 secretion from microglia [153]. This is similar to our observation of galectin-9
mediated potentiation of F. novicida induced inflammatory response. In our studies,
consistent with the property of a typical alarmin, galectin-9 exhibited immune activating
properties such as stimulation of the oxidative burst in neutrophils and inflammatory
cytokine production in macrophages. Importantly, this lectin was able to augment F.n.
infection induced inflammatory responses from neutrophils as well as macrophages,
which can have important implications under in vivo conditions. Consistent with this proinflammatory activity of galectin-9, Gal-9-/- animals exhibited a reduction in the levels of
inflammatory cytokines such as TNF-α, IL-6 and IL-1 during F.n. infection. Studies from
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our laboratory have shown that pulmonary infection with F.n., as well as F. tularensis,
results in extensive cell death [74]. It is likely that during pulmonary Francisella
infection, galectin-9 released from dead cells primes the myeloid cells to produce
heightened levels of inflammatory mediators in response to the bacteria. Furthermore,
since galectin-9 can be upregulated and released from cells upon exposure to proinflammatory stimuli such as cytokines and TLR ligands [154], the activated cells likely
release more galectin-9 resulting in a positive feed-back loop causing further tissue
damage and ultimately organ failure, characteristic of sepsis. This is also supported by
our unpublished observations showing that bone marrow derived macrophages from Gal9-/- mice show impaired activation upon stimulation with TLR-4 ligand LPS. This
immune stimulatory activity of galectin-9 in the context of Francisella infection is in line
with a previous study showing the role of the prototype alarmin HMGB1 in promoting
the inflammatory response of monocytes elicited by external stimuli [98].
As a result of mitigated inflammatory responses and tissue pathology, the survival of F.n.
infected Gal-9-/- mice was significantly improved as compared to the WT mice which
succumbed to infection by day 5-6. Interestingly, we observed similar bacterial burdens
in the lungs of F.n. infected Gal-9-/- and wild-type mice. However, the bacteremia was
delayed in Gal-9-/- mice with significantly lower burden in blood at 2dpi but the
difference at later points as was not statistically significant as compared to the WT mice.
Galectin-9 has been shown to mediate phagocytosis of P. aeruginosa by neutrophils thus
contributing to bacterial clearance [144]. In contrast, a similar bacterial burden in WT
and Gal-9-/- mice in our study indicates that galectin-9 does not play a role in F.n.
clearance. Because of high bacterial burden, a majority of Gal-9-/- mice ultimately
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succumbed to infection. These results are similar to our recently published studies of
galectin-3 function in F.n. induced sepsis. In this scenario a combinatorial approach
using blockade of galectin-3 and galectin-9 along with antibiotics could potentially treat
Francisella infection induced sepsis. Additionally, in order to address any possible
synergistic effect of galectin-3 and -9 (since we have found that these are the only two
galectins, out of nine tested by us, which are upregulated and are likely released in
Francisella infected lungs), we have already generated galectin-3/galectin-9 double
knock-out mice and are currently analyzing them for sepsis development during bacterial
infection. In light of a similar alarmin-like function of these galectins, the double knockout mice may exhibit further improvement in the disease outcome.
Together our findings indicate that galectin-9 plays a pathogenic role as an alarmin to
exacerbate the inflammatory response during pulmonary infection with Francisella and
contributes to sepsis development. Galectin-9 thus may represent a potential target for
treatment of sepsis during this infection.
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Abstract
Background: Nosocomial infections with Klebsiella pneumoniae (KPn) are a frequent
cause of Gram-negative sepsis. To understand the functioning of host innate immune
components in this disorder, we examined a previously uninvestigated role of C-type
lectin receptor Mincle, in pneumonic sepsis caused by KPn.
Methods: Disease progression in wild-type and Mincle-/- mice undergoing pulmonary
infection with KPn was compared.
Results: While the wild-type mice infected with a sublethal dose of bacteria could resolve
the infection with bacterial clearance and regulated host response, the Mincle-/- mice were
highly susceptible with a progressive increase in bacterial burden despite their ability to
mount an inflammatory response which turned to an exaggerated hyperinflammation with
the onset of severe pneumonia. This correlated with severe lung pathology with a massive
accumulation of neutrophils in their lungs. Importantly, Mincle-/- neutrophils displayed a
defective ability to phagocytize non-opsonic bacteria and an impaired ability to form
extracellular traps (NETs), an important neutrophil function against invading pathogens,
including KPn.
Conclusion: Our results demonstrate protective role of Mincle in host defense against
KPn pneumonia by coordinating bacterial clearance mechanisms of neutrophils. A novel
role for Mincle in regulation of NETosis may have implications in chronic disease
conditions characterized by deregulated NET formation.

96

Introduction
Lower respiratory tract infection with bacteria can lead to sepsis development, which is a
complex immune disorder characterized by a systemic hyperinflammation. There are
currently no effective therapies for sepsis that results in 750,000 hospitalizations annually
in the United States with a mortality rate of 20-50% [5,155]. Nosocomial infections with
opportunistic pathogen Klebsiella pneumoniae (KPn) account for 5-20% of Gramnegative sepsis cases [117-119]. Additionally, emergence of multidrug resistant isolates
of KPn in clinical settings is a serious health concern. As innate mucosal immunity plays
a direct role in bacterial killing and immunomodulation in this acute infection [126,156159], an understanding of functioning of host innate immune components might provide
targets for modulation of host immune system in a beneficial manner.
Mincle is a C-type lectin receptor (CLR) belonging to the Dectin-2 subfamily of innate
immune receptors that can function as an activating receptor for host- as well as
pathogen-associated molecular patterns, termed alarmins and PAMPs respectively
(reviewed in [49,160]. It is an inducible receptor, expressed mainly by myeloid cells such
as macrophages, neutrophils, myeloid dendritic cells as well as some B-cell subsets [160162].

Functional analysis of this receptor in macrophages has received the most

attention, where its association with FcRγ activates downstream signaling cascades
involving Syk kinases resulting in induction of protective inflammatory response [163165]. While the function of Mincle in chronic bacterial infections such as tuberculosis
and fungal infections was examined in these studies, its role in acute pneumonic
infections leading to sepsis development has not been explored. Furthermore its functions
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other than as an inflammatory PRR (Pattern Recognition Receptor) have received little, if
any, attention.
Neutrophil mediated responses are essential for combating pneumonic bacterial infection
and their protective role in sepsis and KPn infection in particular has been described
[128,138]. The professional antimicrobial program of neutrophils mainly constitutes
phagocytosis of infectious agents followed by production of noxious agents such as
reactive oxygen species which kill the internalized microbes. Another recently
established mechanism of microbial killing by neutrophils is by formation of extracellular
traps (termed neutrophil extracellular traps or NETs) which are DNA fibrils expelled by
these cells that are decorated with granular contents such as various proteases and can
ensnare and kill the microbes without phagocytosis [166-168]. Mincle has been shown to
be expressed by neutrophils and while shown to play a role in neutrophil mediated
protective responses against Candida and mycobacteria [169,170], its direct role in
bacterial phagocytosis and NET formation is not known. Since neutrophils are a key cell
type in controlling KPn infection, Mincle signaling in neutrophils may be a key event in
control of KPn infection and sepsis.
In this study we examined the role of Mincle in acute KPn infection causing pneumonic
sepsis. Our results suggest novel protective function of Mincle as non-opsonic phagocytic
receptor for the bacteria and in regulation of neutrophil NET formation indicating the
importance of this CLR in neutrophil-specific bacterial clearance mechanisms in
pneumonic infections.
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Methods
Bacterial strains and Mice
The KPn (ATCC strain 43826) were grown to log phase in LB medium at 37oC. All invivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 or
Mincle-/- mice on same background obtained from the Consortium of Functional
Genomics, Scripps, La Jolla and bred in the animal facility of the University of North
Dakota. The animals were used according to institutional and federal guidelines.
Infection of Mice, survival and bacterial burden
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in
PBS and were infected intranasally with sublethal dose (2.5 x 104 bacteria in 20ul of
saline, determined experimentally) of KPn or with 20 µl of saline alone. Survival of the
mice was recorded for up to 2 weeks post-infection (p.i.). In some experiments, the mice
were euthanized at indicated times p.i. and blood, lungs and liver were aseptically
homogenized in cold PBS with CompleteTM protease inhibitor cocktail (Roche
Diagnostics, Germany). For the bacterial burden analyses, serially diluted homogenates
and blood were plated on LB agar and incubated at 37oC overnight.
Quantitative real-time PCR
Total RNA from lungs of infected and mock control mice harvested at various times p.i.
was extracted using Trizol reagent (Invitrogen) according to the manufacturers'
instructions. Real-time PCR analysis was performed using SYBR green (Applied
Biosystems, CA, USA) to measure the expression levels of Mincle-specific mRNA by
using specific primers (sense) 5'- ACC AAA TCG CCT GCA TCC -3' and (anti-sense)
5'- CAC TTG GGA GTT TTT GAA GCA TC -3' (as described by us in [1]. The target
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gene expression levels were normalized to levels of the house keeping 18S gene in the
same sample. Expression of Mincle in infected samples was determined as fold change
over that in control samples as calculated by using the formula 2−(ΔΔCt).
Multi-analyte profile analysis
The lung homogenates were prepared as described for the bacterial burden analysis above
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants
were immediately frozen at -80o C. The biomarker levels in lung homogenates were
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing
a multiplexed analysis.
Histological analysis
For histological analysis, frozen lung tissues were processed as previously described
[77,82]. Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were
stained with hematoxylin and eosin for pathological analysis as previously described
[3,89] .
Flow Cytometry
Lungs or BAL cells were harvested from mice at 3 days p.i. and processed as previously
described by us [77,78,82]. Enumeration of neutrophils by flow cytometry (using a BD
LSR II, Becton Dickinson, San Jose, CA) was done by quantitating Ly6G+CD11b+ cells
stained with Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G (Clone 1A8)
antibodies (Biolegend, San Diego, CA). Mincle expression was examined by using a rat
anti-mouse Mincle monoclonal antibody (Clone 6G5, InvivoGen, CA) followed by goat
anti-rat Alexa-488 secondary antibody (InvitroGen, OR). FlowJo (Tree Star) software
was used to analyze all data.
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Bacterial phagocytosis by neutrophils
Bacterial phagocytosis of WT and Mincle-/- neutrophils was assessed by flow cytometry.
For this peritoneal neutrophils were isolated using an established model of thioglycollateinduced peritonitis. Sterile 4% thioglycollate was injected in peritoneal cavity of mice
and neutrophils enriched 8-12h following the injection were isolated (95-99% pure as
assessed by flow cytometry using GR1 and CD11b antibodies). Neutrophils were
incubated with GFP-labeled KPn (kindly provided by Dr. Steven Clegg, University of
Iowa) for 1 hour and washed three times with ice-cold FACS-buffer (PBS+10% fetal
bovine serum). Fluorescence of the attached but non-internalized bacteria was quenched
by treating the cells with 0.04% Trypan Blue. The % positive cells containing fluorescent
bacteria were determined by flow-cytometry using uninfected neutrophils as control.
Neutrophil NETs
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was
performed in WT and Mincle-/- mice at 3dp.i.. The lavage cells were cytocentrifuged on
glass slides and were co-stained with Sytox Green (Molecular Probe, Eugene, OR) and
rabbit anti-neutrophil elastase (NE) polyclonal antibody (abcam, ) followed by goat antirabbit Alexa546 antibody. The percent NET formation was quantitated by dividing the
number of NET-forming neutrophils by total number of cells in 8-10 random microscopic
fields and multiplying the values by 100.
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Statistical Analysis
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test;
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose,
CA).
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RESULTS
Mincle is highly expressed in lungs during pneumonic KPn infection.
To examine the role of innate immune receptors in pathogenesis of KPn induced
pneumonic sepsis, we initially screened a panel of 52 membrane-bound and soluble
CLRs by Taqman Low-density arrays which showed

an upregulated expression of

Dectin-2 family CLR, Clec4e (also called Mincle), among others in the lungs of mice
undergoing respiratory KPn infection. To further confirm the Mincle expression, realtime quantitative PCR was performed using RNA from lungs of KPn infected wild-type
mice. The results showed a progressive increase in the transcript level of Mincle mRNA
which was maximally transcribed by 3dp.i. and remained at high level throughout the
course of infection (Figure 17A).

Flow cytometry analysis further confirmed the

increased numbers of Mincle-positive cells, majority of which were CD11b+Ly6G+
neutrophils, in the lungs of KPN-infected mice (Figure 17B). This indicated that Mincle
was highly expressed on neutrophils and played a role in pathogenesis of KPn
pneumonia.
Mincle deficient mice are highly susceptible to KPn pneumonia.
To examine the role of Mincle in disease development, overall disease severity and
survival was compared in wild-type and Mincle-/- mice infected with a sub-lethal dose of
KPn. This dose was experimentally determined at which the WT mice displayed minimal
morbidity and mortality [3]. As shown in Figure 17C, 76% of WT mice infected with
2.5x104 CFUs of KPn survived the infection with transient signs of disease (ruffled fur,
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positive cells were gated and further analyzed for expression of CD11b and Ly6G as
mentioned in the Methods section. The dot plots shown are representative of
3independent experiments with 3 mice each. C. Fifteen each WT and Mincle-/- mice were
intranasally infected with 2.5X104 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile
PBS and were assessed daily for disease severity. The survival was monitored for two
week. Statistical comparison of susceptibility was done by Kaplan-Meier survival curve
statistical analysis (p<0.001).
lethargy) early during infection and appeared healthy later. The Mincle-/- mice, in
contrast, were extremely susceptible to this dose and all mice succumbed to infection by
day 6p.i. While majority of the infected WT mice cleared the infection by day 5 p.i.,
Mincle-/- mice exhibited progressive development of disease and overt signs of infection
(weight loss, piloerection, hunched gait, lethargy, increased respiratory rate). The
increased susceptibility of Mincle-/- mice clearly indicated a protective role played by this
CLR during pneumonic KPn infection.
Mincle deficiency results in increased bacterial burden and systemic disseminatio
In order to examine if increased susceptibility of Mincle-/- mice to KPn infection
correlated with inefficiency to clear bacteria, homogenized lungs, liver and blood from
infected Mincle-/- and WT mice collected at various times post infection were plated on
LB agar. Up to 2dp.i., Mincle-/- and WT animals displayed similar bacterial burdens in
their lungs (Figure 18A). By 3dp.i., however, lungs of Mincle-/- mice exhibited
significantly higher bacterial counts as compared to their WT counterparts. The bacterial
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Figure 17. Mincle is highly induced in the lungs of KPn infected pneumonic mice
and Mincle deficiency increases susceptibility to the infection.
A. Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type
C57/BL6 mice, harvested at indicated time post-infection. The mRNA levels of Mincle
were analyzed by real-time PCR as described in Methods and are expressed as fold
changes over the levels in mock control mice calculated by using the formula 2−(ΔΔCt).
Data shown are the averages of 6-8 mice per group in two independent experiments. B.
Mincle expression was examined on infiltrating lung cells from KPn infected wild-type
C57/BL6 mice harvested at 3dp.i. by flow cytometry using a rat anti-mouse Mincle
antibody followed by goat anti-rat secondary antibody labeled with Alexa-488. Mincle
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burden in these mice remained high at 5dp.i., the time when majority of mice had become
moribund. In contrast, the WT mice displayed 3-5 logs lower bacterial burden at 3dp.i.
and the counts continued to drop through 5dp.i., indicating clearance of bacteria and
resolution of the infection in these mice. The Mincle-/- mice also displayed a higher
systemic dissemination of bacteria as depicted by significantly higher bacterial load in
liver (Figure 18B) and a more severe bacteremia (Figure 18C). In contrast, no viable
bacteria were detected in the blood of WT mice by 5dp.i. These data indicated that
Mincle mediated responses directly or indirectly influenced bacterial clearance in
pneumonic
Mincle-/- mice exhibit hyperinflammatory response
We next examined if the inability of Mincle-/- mice to clear the bacteria was due to a
defect in mounting inflammatory response. In both WT and Mincle-/- strains, mock
infected mouse lungs displayed similar low basal levels of inflammatory cytokines tested
(Figure 19). Upon KPn infection, WT mice exhibited increased levels of these cytokines
at 1dp.i., which started to drop by 3dp.i. and were reduced to minimal levels by 5dp.i.
(Figure 19). This was consistent with the reduced bacterial burden in these mice at these
times p.i.. In contrast, infection of Mincle-/- mice resulted in a progressive increase in
levels of these cytokines through the course of infection, which remained high till the
mice became moribund. These mice in fact exhibited an overwhelming inflammatory
response at 3d and 5dp.i. (Figure 19). The levels of inflammatory cytokines and
chemokines tested in lungs of these mice were significantly higher than WT mice at these
infection with KPn.
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Figure 18. Mincle-/- mice display increased bacterial burden and systemic
dissemination during pneumonic KPn infection.
WT and Mincle-/- were intranasally infected with 2.5X104 CFUs of KPn. At indicated
times post infection the mice were sacrificed, systemic organs were isolated,
homogenized and plated as described in Materials and Methods. Bacterial burden was
enumerated after incubating the plates overnight at 37oC. The data shown is from three
independent experiments with 3-5 mice at each time point per experiment. Significant
differences in bacterial burden (using non-parametric Mann-Whitney test) in WT and
Mincle-/- are denoted by asterisks (*, p<0.05; **, p<0.005, ***p<0.001).
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time points. The levels of IL-10, an anti-inflammatory cytokine were also significantly
higher in Mincle-/- mice, suggesting a condition of “cytokine storm” typical of sepsis,
where anti-inflammatory host mediators are upregulated in an attempt to counter-balance
the systemic inflammatory response [171-173]. These results show that Mincle
deficiency did not render the mice defective in their ability to mount an inflammatory
response but these mice rather displayed a hyperinflammatory phenotype typically
associated with sepsis. Our observations thus raised the possibility that Mincle likely
plays a direct role in bacterial clearance and the hyperinflammation resulted due to
activation of other PRRs and inflammatory receptors in response to persistent
overwhelming bacterial burden in Mincle-/- mice undergoing pneumonic KPn infection.
Effect of Mincle deficiency on neutrophil infiltration and overall lung pathology
Since neutrophils are a key cell type involved in bacterial clearance and initiation of
protective immune response during KPn pneumonia, we next compared neutrophil
infiltration and gross immunopathological changes in KPn infected WT and Mincle -/mice. The mock control mice of both strains displayed similar normal lung tissue
morphology in H&E stained sections (Figure 20). A moderate transient infiltration of
immune cells was observed substantially by 5dp.i. The overall architecture of the lungs
was largely preserved in the WT animals throughout the infection. The Mincle-/- mice, on
the other hand, displayed a progressive increase in immune cell infiltration, which were
mainly neutrophils, based on characteristic multi-lobed nuclei (Figure 20 inset). By day 3
p.i. substantially increased in infected WT mice by day 3p.i. which was reduced
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Figure 19. Pneumonic Mincle-/- mice exhibit hyperinflammatory response.
The lungs from mock control and KPn infected WT and Mincle-/- mice were harvested at
indicated time points post-infection, homogenized in PBS with protease inhibitors and
analyzed commercially for host immune mediators by rodent multi-analyte profile
(MyriadTM Rules-Based Medicine, Austin, TX). Results shown are average of 3-4 each
infected and mock control mice from 3 independent experiments. Amounts of mediators
shown were significantly higher (***p<0.001) in KPn infected Mincle-/- mice at 3dp.i.
and 5dp.i. in comparison with their levels in the infected WT mice at those time points
tested.
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Figure 20. Pneumonic Mincle-/- mice exhibit severe lung pathology characterized by massive neutrophil
accumulation.

Hematoxylin & Eosin staining of lung cryosections from mock control and KPn infected WT and Mincle-/- mice

isolated at indicated times post-infection. Magnification 100X. Inset shows a highly magnified area (1000X) of a

lesion in infected Mincle-/- lung depicting neutrophils as indicated by characteristic multilobed nuclear morphology.
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influx of cells was observed in large lesions and by 5 p.i., extensive foci of consolidation
were visible with massive accumulation of neutrophils around alveolar spaces (Figure
20). Flow cytometry analysis of infiltrating cells in lungs confirmed that the majority of
these cells were Ly6G+CD11b+ neutrophils (Figure 21A). The numbers of these cells
were significantly higher in the infected Mincle-/- lungs than those in the WT mice (Fig.
21A, bar graph).

This correlated with significantly higher levels of neutrophil

chemoattractants (CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and
neutrophil activation markers (MMP9, MPO) in these mice, as compared to their WT
counterparts (Figure 21B).
Mincle-/- neutrophils are defective in KPn phagocytosis
We next examined the bacterial uptake by Mincle-/- neutrophils, in light of an increased
bacterial burden in Mincle-/- mice. For this, phagocytosis of GFP-labeled KPn was
compared between WT and Mincle-/- neutrophils by flow cytometry. As shown in Figure
22, Mincle deficiency resulted in significantly reduced phagocytosis of non-opsonized
bacteria by neutrophils. The uptake of opsonized bacteria was also reduced in Mincle-/neutrophils as compared to the Mincle-sufficient WT cells, however the differences were
not statistically significant. These results indicate that Mincle is likely a novel nonopsonic phagocytic receptor for KPn and plays an important role in bacterial uptake by
neutrophils.

111

Figure 21. Increased neutrophil accumulation coincides with elevated expression of
neutrophil chemoattractant and activation markers in lungs of KPn infected Mincle/-

mice.

A. Flow cytometry analysis of Ly6G+CD11b+ neutrophils in mock control (WT-M and
Mincle-/--M) and KPn infected (WT-Inf and Mincle-/--Inf) WT and Mincle-/- mice. Total
lungs cells were isolated from mice by collagenase treatment at 3dp.i.. The cells were
stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for
neutrophils. The bar graph shows average of total number of neutrophils in lungs of 2-3
mock control and 3-4 KPn infected WT and Mincle-/- mice each from 3 independent
experiments. Dot plots shown on the right are from one representative experiment.
Statistical significance are denoted by asterisks (***, p<0.001). B. The lungs from mock
control and KPn infected WT and Mincle-/- mice were harvested at indicated time points
post-infection and analyzed commercially for host immune mediators by rodent multianalyte profile (MyriadTM Rules-Based Medicine, Austin, TX). Levels of neutrophil
chemoattractants (CXCL2, CXCL6, GM-CSF) and activation markers (matrix
metalloproteinase 9, MMP-9 and myeloperoxidase, MPO) shown are average of 3-4 each
infected and mock control mice from 3 independent experiments. Amounts of mediators
shown were significantly higher (***p<0.001) in Mincle-/- mice at 3dp.i. and 5dp.i. in
comparison with their levels in the WT mice at those time points tested.
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Figure 22. Mincle deficiency impairs neutrophil phagocytosis of non-opsonized
bacteria.
Peritoneal neutrophils from WT and Mincle-/- mice were incubated with GFP (Green
Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized) 10%
normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow
cytometry. The results are expressed as % cells positive for fluorescent bacteria.
Significant differences are denoted by asterisks (**, p<0.005).
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Mincle-/- neutrophils are defective in NET formation
Extracellular trap formation is an important mechanism by which neutrophils clear
extracellular bacteria. Since Neutrophil NET mediated killing has been shown to play a
role in KPn clearance [156,174], we saught to determine if Mincle deficiency resulted in
a defect in NET formation. In order to minimize the tissue processing to avoid
degradation of NETs, neutrophils isolated from BAL were used. Flow cytometry analysis
showed that neutrophils were a predominant cell-type in the BAL of infected WT and
Mincle-/- mice (Figure 23A). A quantitative comparison of BAL neutrophils showed that
significantly higher numbers Mincle sufficient WT neutrophils produced NETs
(Figure23B) which stained positive for neutrophil-specific enzyme neutrophil elastase
(Figure 23C), showing that these fibrillar structures originated mainly from neutrophils.
Furthermore, the NETs observed in Mincle-/- neutrophils appeared dwarfed and lacked
the web-like appearance as observed in the WT mice. This observation, together with
phagocytic ability of Mincle-/- neutrophils shows that Mincle deficiency severely impairs
neutrophil mediated bacterial uptake and clearance mechanisms in lungs during
pneumonic KPn infection.
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Figure 23. Mincle deficiency causes a defect in formation of neutrophil extracellular
traps (NETs) in the lungs of mice upon pneumonic KPn infection.
A. Enumeration of CD11b+Ly6G+ neutrophils by flow cytometry in BAL isolated from
KPn infected WT and Mincle-/- mice. B. Quantitation of neutrophils showing NETs in
BAL isolated from WT and Mincle-/- mice infected with KPn. (***p<0.001). C.
Representative fluorescence images of the neutrophils isolated from BAL fluid of WT
(upper panel) and Mincle-/- (lower panel) mice infected with KPn, and stained with Sytox
Green to label DNA (green) and a rabbit anti-neutrophil elastase (NE) polyclonal
antibody followed by goat anti-rabbit Alexa546 (red). The neutrophils from WT mice
showed web-like structures that stained positive for NE and Sytox green (white arrow),
while the Mincle-/- neutrophils appeared inactive and displayed occasional small DNA
fibers that lacked the typical web-like appearance of NETs (blue arrow). The experiment
was repeated 3 times with 3-4 mice in each group. Magnification 400X.
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DISCUSSION

Pneumonic sepsis is a major health care burden worldwide and K. pneumoniae (KPn) is
the most frequent Gram-negative sepsis-associated opportunistic pathogen [155]. An
imbalance of innate immune responses resulting in deleterious and prolonged
inflammation and impairment of protective functions of first responder cells such as
neutrophils have been directly correlated with sepsis-associated mortality [26,175,176].
This warrants an improved understanding of functioning of innate immune components
in this deadly disease. In this study, we sought to determine the role of Mincle, an innate
immune C-type lectin receptor in KPn pneumonia. Here we report several novel findings:
1) We show, for the first time, a clear phenotype in terms of a severely reduced survival
rate of Mincle-/- mice upon pneumonic KPn infection; 2) the reduced survival is not due
to a defect in ability to mount an inflammatory response in absence of Mincle; 3) Mincle
acts as a non-opsonic phagocytic receptor mediating uptake of KPn by neutrophils; and
4) Mincle deficiency results in a defect in neutrophil NET formation upon KPn infection.
Our results

thus show that Mincle is required for defense against KPn induced

pneumonic sepsis and that lack of Mincle causes a defect in neutrophil mediated bacterial
clearance mechanisms such as phagocytosis and NET formation.
Mincle has been previously shown to play a role in eliciting inflammatory responses
against Mycobacterium, Candida albicans and skin fungal pathogens, Malassezia and
Fonsecaea [165,177-179]. In these infections, Mincle expressed on macrophages, upon
recognition of its ligands triggers FcRγ-Syk-Card9 pathway to induce production of
protective Th1/Th17 responses as well as chemokines required for recruitment of
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inflammatory cell types [164,178,180]. The increased susceptibility to these infections
in the absence of Mincle was measured in terms of increased bacterial and fungal burden
which was attributed to reduced inflammatory response and defective pathogen clearance
in these studies. However, overall survival of the experimental animals was not affected
by Mincle deficiency. Our study for the first time, reports a clear outcome where Mincle
seems to play a non-redundant role in survival of KPn infected pneumonic mice.
Moreover, the reduced survival of Mincle-/- mice is not due to their inability to mount an
inflammatory response. These mice, instead exhibit hyperinflammation in their lungs
suggesting that the protective ability of Mincle was independent of its role in eliciting
inflammatory response. It is likely that the redundant function of other PRRs, upon
recognition of bacterial PAMPs and endogenous alarmins generated from increased
bacterial growth and accumulation of dead cells over time, is sufficient to induce
inflammation in the absence of Mincle. Indeed, Mincle-/- mice in our studies, exhibited
overwhelming local as well as systemic bacterial burdens.
Concomitant to increased bacterial burden, Mincle-/- mice exhibited extensive neutrophil
accumulation, the primary cell type shown to play an important role in mediating
protective immune response against Kpn infection [117,126,138,181]. We thus examined
if Mincle-/- neutrophils were defective in performing cellular functions such as
internalization of bacteria via phagocytosis which would explain increased bacterial
burden in Mincle-/- mice despite a heightened inflammation. Indeed, Mincle-/- neutrophils
showed a mitigated phagocytosis of non-opsonized, but not opsonized KPn, suggesting a
non-redundant and direct role of Mincle for internalization of non-opsonized bacteria. To
the best of our knowledge, this is the first study reporting Mincle as a non-opsonic
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phagocytic receptor. Ongoing studies in our lab are currently investigating Mincle
specific ligand of KPn, nature of this interaction and production of specific antibodies
that can inhibit this interaction.

Lectinophagocytosis or lectin-mediated uptake by

macrophages has been reported previously for several pathogens (reviewed in [182].
However, the receptors or mechanisms of non-opsonized phagocytosis of bacteria by
neutrophils are poorly understood. Non-opsonic phagocytosis by receptors like Mincle
may be important during early stages of infection before the onset of humoral immunity
to generate opsonins, and in complement deficient or immunosuppressed patients. This
mode of phagocytosis is particularly significant for inhaled bacteria as serum and
complement components are as such limited in the alveolar space [183]. Although
appearance of serum components in alveolar space is common during severe KPn
pneumonia, owing to high binding capacity of Mincle to mannose and Nacetyleglucosamine [184], uptake by Mincle of KPn with mannan-rich capsule in lungs
could be a major mechanism of bacterial clearance in lungs. Absence of Mincle and a
resulting defect in initial phagocytic uptake of KPn, as observed in our studies likely
contributes to the increased bacterial burden and subsequent inflammation via activation
of other PRRs such as TLRs.
One of the more recently defined mechanisms of antimicrobial activity of neutrophils is
extrusion of fibrous mesh of chromatin that entraps extracellular pathogens [166]. These
structures, termed NETs, are decorated with antimicrobial factors normally contained
within neutrophil granules and represent an important strategy of neutrophils to
immobilize and kill pathogens. Our observation reported in this study that Mincle-/neutrophils are defective in NET formation in-vivo during KPn infection coincides with
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overwhelming bacterial burdens in these mice. These results are in line with previous
reports indicating that NET mediated killing is an important mechanism of bacterial
clearance and protection against KPn induced pneumonia [156,174]. How Mincle
regulates NET formation is currently under investigation in our laboratory and is
expected to provide novel insights into mechanism of NETosis. This will have important
implications in chronic disease conditions where deregulated NET formation is
associated with the pathophysiology.
Taken together, our results show that Mincle plays a protective role in KPn induced
pneumonic sepsis by regulating neutrophil phagocytosis and NET formation, two
important mechanisms of antimicrobial activity of neutrophils. Particularly, the novel
observation of Mincle as a potential new component of NETosis pathway implicates this
CLR in a much wider range of biological functions that initially surmised.
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General Discussion
Sepsis is a complex immune disorder that results in 750,000 hospitalizations annually in
the United States alone [185]. Pulmonary infections, in turn, are a major cause of sepsis
[5]. In addition to posing an immense health hazard with a mortality rate of 20-50%, it is
also a huge economic healthcare burden with the patients consuming half of the ICU
resources in the country. In October 2011, the only FDA approved drug for the treatment
of sepsis (Xigris) was withdrawn from market following the much anticipated results of
the clinical trial (PROWESS-SHOCK) where it failed to show any survival benefit for
severe sepsis and septic shock patients [186]. As a result we are now left with no
effective preventive or treatment options for this deadly immune disorder. As clinical
presentations of sepsis are known to be caused by an unbridled hyper-inflammatory
responses causing massive tissue pathology leading to multiple organ failure [23,28], our
major goal was to identify mechanisms responsible for pulmonary infection-induced
sepsis development. In this regard, most of the sepsis research has been focused on
initiation of inflammatory response upon pathogenic insult and the role of pathogen
associated molecules or PAMPs [28]. However, our earlier studies with Francisella, a
Gram-negative pathogen, demonstrated that pulmonary infection with this bacterium
leads to development of severe sepsis and systemic organs failure despite absence of any
bacterial toxins [73,78,80]. Moreover, LPS which is the major PAMP in Gram negative
bacterial pathogens, is modified in Francisella and as a result, does not stimulate
TLR4and is thus hypo-inflammatory [187]. As our and other laboratories have clearly
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shown that extensive tissue damage is a hallmark of sepsis, our initial hypothesis was that
endogenous molecules released from the dead or dying cells contribute and/ or exacerbate
the host inflammatory response culminating in sepsis development. Thus, our first goal
was to identify novel self-molecules termed as alarmins that are released from dead/dying
cells and their role to regulate induction and/ or exacerbation of host inflammatory
response. An efficient recognition and clearance of the damaged cells by efferocytosis is
essential to prevent inflammatory response due to PRR-alarmin interaction. Thus,
efferocytosis is an important step for resolution of inflammation and maintenance of
normal body physiology. Therefore, our second goal was to identify novel host cell
surface receptors involved in efferocytosis. In this regard, the importance of the lectins in
host immunity and homeostasis has been demonstrated in several recent studies in
different clinical settings [55,56]. Lectins are involved in recognition of glycan structures
on a wide range of antigens [188], including cryptic self-antigens that are exposed by cell
death or are modified during disease conditions, leading to inflammation [189]. In
contrast, studies have also shown that lectins mediated recognition and sampling of selfglycan antigens ensures a state of immune tolerance helping to maintain normal body
physiology. Indeed, it has been established that lectins are important biological regulators
in eliciting immune suppression [190-193]. Owing to such dual functions of lectins in
induction as well as resolution of inflammation in various clinical settings, here we
focused to characterize lectins that can function as novel alarmin or alarmin receptor to
regulate inflammatory pathology in pulmonary bacterial infection induced sepsis.
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Lectins as novel alarmins and their function in induction/ exacerbation of
hyperinflammatory response in pneumonic sepsis: role of galectin -3 and -9

Extracellular presence and induction of inflammation
Alarmins: a) are endogenous molecules typically perform homeostatic functions when
contained within cellular compartments; b) can be found extracellularly despite lacking
any signal sequence for active secretion; c) have chemoattractant and immune activating
properties; and d) exhibit immune enhancing properties when injected in-vivo
[26,29,30,84]. Galectins constitute the only soluble mammalian lectins which do not
contain any secretion signal sequence [66]. Consistent with the property of alarmins,
galectins play homeostatic roles [63]. We first analyzed the expression and distribution of
galectins 1-13 in uninfected and Francisella infected lung tissues. Francisella infection
was found to upregulate the expression of many galectins including galectin-3 and
galectin-9. Interestingly, out of all galectins tested, only galectin-3 and galectin-9
exhibited extracellular presence. Such upregulated and extracellular expression suggested
possible alarmin functions for these molecules in infection and pathological processes
[63,64,66,137] associated with sepsis. As alarmins can induce and/or exacerbate
inflammatory responses from myeloid cells such as macrophage and neutrophils that are
typically associated innate immune responses, effect of galectin-3 and -9 on these cells
was examined. Purified recombinant galectin-3 and -9 exacerbated F. novicida-induced
production of the inflammatory mediators by macrophages and neutrophils.
Notwithstanding the mechanisms involved in the disparity of inflammatory mediators
induction by recombinant galectin-3 and -9 alone, clearly both these molecules
augmented infection induced inflammatory response in myeloid cells. Similar studies
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involving a prototype alarmin HMGB1 have also reported that while HMGB1 by itself
failed to induce inflammatory mediators in macrophage, it exacerbated agonist-induced
inflammatory mediator productions [31,32]. Increased extracellular release of galectin-3
and -9 in Francisella infected lungs, and their ability to increase production of
inflammatory mediators likely is the primary contributor to the tissue damage observed
during pulmonary Francisella infection-induced sepsis.

Inflammation and disease phenotype in vivo:
In order to further establish a role for galectin-3 and -9 in murine sepsis, Francisella
infected galectin-3-/- and galectin-9-/- mice were analyzed for overall disease
pathogenesis. As both galectin-3 and -9 exposure enhanced development/ exacerbation of
infection induced inflammation in myeloid cells in vitro, we speculated that in the
absence of galectin-3 and galectin-9 Francisella-infected mice would display reduced
systemic inflammation. Indeed these mice showed a reduced level of inflammatory
mediators, including multitude cytokines and chemokines, many of them markers of
sepsis. Additionally, a reduced number of neutrophils in lungs after Francisella infection
was observed in both galectin-3-/- and galectin-9-/- mice. The results further suggest a key
role for galectin-3 and galectin-9 as critical modulators of inflammatory response during
bacteria induced murine sepsis. Since these mice also display decreased systemic tissue
pathology, the results are consistent with alarmin properties playing a role in
exacerbating inflammation induced tissue pathology which is detrimental to host in
sepsis. Intriguingly, despite the fact that Francisella infected galectin-3-/- and galectin-9-/mice exhibit improved survival, these infected mice eventually succumbed to infection
which correlated with similar bacterial burdens in the knock-out and wild-type mice. It is
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possible that, high bacterial burden contributes to increased cell death, albeit at a lower
level as compared to the corresponding WT mice, leading to an increased accumulation
of other alarmins which eventually mask the advantageous effect of the absence of
galectin-3 and -9. Thus persistence of alarmins released by the damaged tissue and
bacteria along with associated increased inflammation likely contributes to the mortality
in infected galectin-3-/- and galectin-9-/- mice.

Conclusion
Our findings indicate that both galectin-3 and -9 function as novel alarmins and play a
pathogenic role to exacerbate the inflammatory response during pulmonary infection with
Francisella and contributes to sepsis development. Galectin-3 and -9 thus may represent
combinatorial potential target/s for treatment of sepsis.

Lectins in resolution of inflammation: role of Clec4d
Sepsis is now perceived as interplay of PAMPs (non-self) and alarmins (self) overactivating immune cells leading to an unbridled inflammatory response. As discussed in
the introduction section, our laboratory and others have clearly demonstrated that massive
cell death is a hallmark of sepsis [29,30,78]. Results from the present study discussed
above together with other studies have established the pathogenic role of alarmins, that
can be passively secreted from dead cells, in immunopathology of sepsis. In this regard,
an understanding of the functioning of host innate immune components likely acting as
receptors for alarmins released from dead cells or dead cells is critical. Here, our results
clearly show that Clec4d deficiency, in an otherwise sublethal pulmonary bacterial
infection, leads to a non-resolving hyperinflammatory response. Moreover, this was
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correlated with increased mortality of the infected Clec4d-/- (KO) mice. Interestingly, the
KO mice displayed a massive accumulation of neutrophils in their lungs. Despite this, an
increase in local as well as systemic bacterial burden was observed in these KO mice.
This was not likely due to a dysfunction of neutrophils as bacterial uptake and killing by
neutrophils was found to be unaffected in the KO neutrophils. Thus, we propose that
persistent accumulation of neutrophils and their associated inflammatory response in
lungs likely contributed to tissue destruction as well as inflammation inducing tissue
pathology observed in the KO mice. Accumulation of large numbers of neutrophils in the
lungs of KO mice and higher amounts of their associated inflammatory mediators suggest
that there is a defect in neutrophil turnover in these mice. It is thus possible that Clec4d
plays an important role in mitigating the inflammation during a pneumonic infection, by
facilitating neutrophil turnover.
Neutrophil-mediated responses are essential for combating pneumonic bacterial infection,
and their protective role in sepsis and KPn infection, in particular, has been described
elegantly. However, neutrophils that have infiltrated to the affected site are readily
cleared to prevent bystander tissue destruction, owing to their tissue-destructive cargo.
Indeed, to restore the quiescent state of homeostasis, clearance of infiltrating immune
cells and host cell debris is very critical.
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This is achieved by a process called

Figure 24. Impaired efferocytosis of uninfected Clec4d-/- neutrophils by murine J774
macrophages.
CFSE-labelled dead neutrophils from WT and Clec4d-/- mice were incubated with J774
macrophages at a ratio of 10:1 for 1h at 37⁰C. Flow cytometry was performed and
efferocytosis index calculated as the percent of CFSE positive macrophages. *p<0.05.
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efferocytosis which not only prevents the potential tissue damage caused by alarmins
released from dead/dying cells but also leads to production of specialized lipid mediators
by efferocytic cells which promote tissue repair [194-196]. Not surprisingly, a defective
efferocytosis has been implicated in several acute and chronic inflammatory lung
diseases (reviewed in [197]. We thus speculated that Clec4d plays a protective role in
pulmonary KPn induced sepsis by mediating efferocytosis which resolves inflammation
as well as aids in bacterial clearance. ). Indeed, our preliminary results (presented here)
shows that Clec4d-/- neutrophils are not efferocytized efficiently (Fig.24). Furthermore,
Clec4d-mediated uptake of KPn-infected neutrophils by macrophages aids in control of
infection (data not shown). Thus, we propose that Clec4d-mediated clearance of infected
neutrophils is critical for successful elimination of a pathological insult. Furthermore,
Clec4d-mediated efferocytosis of infected neutrophils and dead neutrophils and their
contents is important in mitigating the inflammation during a pneumonic infection. This
study opens up new avenues of research on the role of Clec4d in the resolution of
inflammatory responses. This can have major implications in the therapeutic
measurements of inflammation-associated disorders.

130

References
1. Mishra BB, Li Q, Steichen AL, Binstock BJ, Metzger DW, et al. (2013) Galectin-3
functions as an alarmin: pathogenic role for sepsis development in murine
respiratory tularemia. PLoS One 8: e59616.
2. Steichen AL, Simonson TJ, Salmon SL, Metzger DW, Mishra BB, et al. (2015)
Alarmin function of galectin-9 in murine respiratory tularemia. PLoS One 10:
e0123573.
3. Steichen AL, Binstock BJ, Mishra BB, Sharma J (2013) C-type lectin receptor Clec4d
plays a protective role in resolution of Gram-negative pneumonia. J Leukoc Biol
94: 393-398.
4. Sharma A, Steichen AL, Jondle CN, Mishra BB, Sharma J (2014) Protective role of
Mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis
and extracellular trap formation. J Infect Dis 209: 1837-1846.
5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001)
Epidemiology of severe sepsis in the United States: analysis of incidence,
outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
6. Wang Z, Su F, Rogiers P, Vincent JL (2007) Beneficial effects of recombinant human
activated protein C in a ewe model of septic shock. Crit Care Med 35: 2594-2600.
7. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in
hospitalization and mortality rates for severe sepsis in the United States: a trend
analysis from 1993 to 2003. Crit Care Med 35: 1244-1250.
8. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the
United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for
sepsis and organ failure and guidelines for the use of innovative therapies in
sepsis. The ACCP/SCCM Consensus Conference Committee. American College
of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
10. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, et al. (1995) The
natural history of the systemic inflammatory response syndrome (SIRS). A
prospective study. JAMA 273: 117-123.
11. Bone RC (1995) Sepsis, sepsis syndrome, and the systemic inflammatory response
syndrome (SIRS). Gulliver in Laputa. JAMA 273: 155-156.
12. Abad CL, Kumar A, Safdar N (2011) Antimicrobial therapy of sepsis and septic
shock--when are two drugs better than one? Crit Care Clin 27: e1-27.
13. Kochanek KD, Xu J, Murphy SL, Minino AM, Kung HC (2011) Deaths: preliminary
data for 2009. Natl Vital Stat Rep 59: 1-51.
14. Lagu T, Higgins TL, Nathanson BH, Lindenauer PK (2012) Incorporating initial
treatments improves the performance of a mortality prediction model based on
administrative data. Crit Care Med 40: 2268-2269; author reply 2269-2270.
15. Mayr FB, Yende S, Angus DC (2014) Epidemiology of severe sepsis. Virulence 5: 411.
131

16. Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, et al. (2010)
Infection rate and acute organ dysfunction risk as explanations for racial
differences in severe sepsis. JAMA 303: 2495-2503.
17. Sordi R, Menezes-de-Lima O, Della-Justina AM, Rezende E, Assreuy J (2013)
Pneumonia-induced sepsis in mice: temporal study of inflammatory and
cardiovascular parameters. Int J Exp Pathol 94: 144-155.
18. Martin GS (2006) Sepsis: the future is bright. Crit Care Med 34: 2484-2485.
19. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, et al. (2009) International study
of the prevalence and outcomes of infection in intensive care units. JAMA 302:
2323-2329.
20. Phua J, Ngerng W, See K, Tay C, Kiong T, et al. (2013) Characteristics and outcomes
of culture-negative versus culture-positive severe sepsis. Crit Care 17: R202.
21. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, et al. (2002)
Epidemiology of sepsis and infection in ICU patients from an international
multicentre cohort study. Intensive Care Med 28: 108-121.
22. Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J (2005) Septic shock;
current pathogenetic concepts from a clinical perspective. Med Sci Monit 11:
RA76-85.
23. Namas R, Zamora R, An G, Doyle J, Dick TE, et al. (2012) Sepsis: Something old,
something new, and a systems view. J Crit Care 27: 314 e311-311.
24. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, et al. (1998) Doubleblind randomised controlled trial of monoclonal antibody to human tumour
necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet
351: 929-933.
25. Reinhart K, Karzai W (2001) Anti-tumor necrosis factor therapy in sepsis: update on
clinical trials and lessons learned. Crit Care Med 29: S121-125.
26. Rittirsch D, Flierl MA, Ward PA (2008) Harmful molecular mechanisms in sepsis.
Nat Rev Immunol 8: 776-787.
27. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, et al. (2012)
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366: 20552064.
28. Lewis DH, Chan DL, Pinheiro D, Armitage-Chan E, Garden OA (2012) The
immunopathology of sepsis: pathogen recognition, systemic inflammation, the
compensatory anti-inflammatory response, and regulatory T cells. J Vet Intern
Med 26: 457-482.
29. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about
danger. J Leukoc Biol 81: 1-5.
30. Manson J, Thiemermann C, Brohi K (2012) Trauma alarmins as activators of
damage-induced inflammation. Br J Surg 99 Suppl 1: 12-20.
31. Lamkanfi M, Dixit VM (2011) Modulation of inflammasome pathways by bacterial
and viral pathogens. J Immunol 187: 597-602.
32. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, et al. (2007) High mobility group
box-1 protein induces the migration and activation of human dendritic cells and
acts as an alarmin. J Leukoc Biol 81: 59-66.

132

33. Foell D, Wittkowski H, Ren Z, Turton J, Pang G, et al. (2008) Phagocyte-specific
S100 proteins are released from affected mucosa and promote immune responses
during inflammatory bowel disease. J Pathol 216: 183-192.
34. Headland SE, Norling LV (2015) The resolution of inflammation: Principles and
challenges. Semin Immunol 27: 149-160.
35. Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, et al. (2014) Contribution of
Defective PS Recognition and Efferocytosis to Chronic Inflammation and
Autoimmunity. Front Immunol 5: 566.
36. Schmidt EP, Tuder RM (2010) Role of Apoptosis in Amplifying Inflammatory
Responses in Lung Diseases. J Cell Death 2010: 41-53.
37. Fullerton JN, O'Brien AJ, Gilroy DW (2013) Pathways mediating resolution of
inflammation: when enough is too much. J Pathol 231: 8-20.
38. Serhan CN, Chiang N, Dalli J (2015) The resolution code of acute inflammation:
Novel pro-resolving lipid mediators in resolution. Semin Immunol 27: 200-215.
39. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, et al. (2005) Sykdependent cytokine induction by Dectin-1 reveals a novel pattern recognition
pathway for C type lectins. Immunity 22: 507-517.
40. Jia XM, Tang B, Zhu LL, Liu YH, Zhao XQ, et al. (2014) CARD9 mediates Dectin1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal
immunity. J Exp Med 211: 2307-2321.
41. Royer PJ, Emara M, Yang C, Al-Ghouleh A, Tighe P, et al. (2010) The mannose
receptor mediates the uptake of diverse native allergens by dendritic cells and
determines allergen-induced T cell polarization through modulation of IDO
activity. J Immunol 185: 1522-1531.
42. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, et al. (2000) The dendritic cell
receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation
via major histocompatibility complex class II-positive lysosomal compartments. J
Cell Biol 151: 673-684.
43. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, et al. (2002) The
dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for
presentation to T cells. J Immunol 168: 2118-2126.
44. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, et al. (2001) BDCA-2, a
novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen
capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med
194: 1823-1834.
45. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR (2002) DC-SIGNmediated internalization of HIV is required for trans-enhancement of T cell
infection. Immunity 16: 135-144.
46. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, et al. (2005) The human
macrophage mannose receptor directs Mycobacterium tuberculosis
lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202: 987-999.
47. Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, et al. (2008) Mincle is an
ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 9:
1179-1188.

133

48. Suzuki Y, Nakano Y, Mishiro K, Takagi T, Tsuruma K, et al. (2013) Involvement of
Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci Rep
3: 3177.
49. Miyake Y, Ishikawa E, Ishikawa T, Yamasaki S (2010) Self and nonself recognition
through C-type lectin receptor, Mincle. Self Nonself 1: 310-313.
50. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, et al. (1998) Lectin-like
oxidized low-density lipoprotein receptor 1 mediates phagocytosis of
aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A 95: 95359540.
51. Yuita H, Tsuiji M, Tajika Y, Matsumoto Y, Hirano K, et al. (2005) Retardation of
removal of radiation-induced apoptotic cells in developing neural tubes in
macrophage galactose-type C-type lectin-1-deficient mouse embryos.
Glycobiology 15: 1368-1375.
52. van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y (2005)
Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic
antigen on colorectal cancer cells through dendritic cell-specific intercellular
adhesion molecule-3-grabbing nonintegrin. Cancer Res 65: 5935-5944.
53. van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk B, et al. (2005)
Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the
recognition of helminth parasites and tumor antigens by dendritic cells. Int
Immunol 17: 661-669.
54. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, et al. (2002) Mannose receptormediated regulation of serum glycoprotein homeostasis. Science 295: 1898-1901.
55. Stuart LM, Henson PM, Vandivier RW (2006) Collectins: opsonins for apoptotic
cells and regulators of inflammation. Curr Dir Autoimmun 9: 143-161.
56. Schagat TL, Wofford JA, Wright JR (2001) Surfactant protein A enhances alveolar
macrophage phagocytosis of apoptotic neutrophils. J Immunol 166: 2727-2733.
57. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. (2001)
C1q and mannose binding lectin engagement of cell surface calreticulin and
CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194:
781-795.
58. Palaniyar N, Clark H, Nadesalingam J, Shih MJ, Hawgood S, et al. (2005) Innate
immune collectin surfactant protein D enhances the clearance of DNA by
macrophages and minimizes anti-DNA antibody generation. J Immunol 174:
7352-7358.
59. Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, et al. (2002) Role
of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and
in vitro: calreticulin and CD91 as a common collectin receptor complex. J
Immunol 169: 3978-3986.
60. Litvack ML, Palaniyar N (2010) Review: Soluble innate immune pattern-recognition
proteins for clearing dying cells and cellular components: implications on
exacerbating or resolving inflammation. Innate Immun 16: 191-200.
61. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, et al. (2007) A pivotal role
for galectin-1 in fetomaternal tolerance. Nat Med 13: 1450-1457.

134

62. Rabinovich GA, Toscano MA (2009) Turning 'sweet' on immunity: galectin-glycan
interactions in immune tolerance and inflammation. Nat Rev Immunol 9: 338352.
63. Liu FT, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochim
Biophys Acta 1572: 263-273.
64. Cerliani JP, Stowell SR, Mascanfroni ID, Arthur CM, Cummings RD, et al. (2011)
Expanding the universe of cytokines and pattern recognition receptors: galectins
and glycans in innate immunity. J Clin Immunol 31: 10-21.
65. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, et al. (2002) Role of galectin-3
as an adhesion molecule for neutrophil extravasation during streptococcal
pneumonia. J Immunol 168: 1813-1822.
66. Sato S, St-Pierre C, Bhaumik P, Nieminen J (2009) Galectins in innate immunity:
dual functions of host soluble beta-galactoside-binding lectins as damageassociated molecular patterns (DAMPs) and as receptors for pathogen-associated
molecular patterns (PAMPs). Immunol Rev 230: 172-187.
67. Ishimura K, Moroguchi A, Okano K, Maeba T, Maeta H (2002) Local expression of
tumor necrosis factor-alpha and interleukin-10 on wound healing of intestinal
anastomosis during endotoxemia in mice. J Surg Res 108: 91-97.
68. Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned.
Shock 9: 1-11.
69. Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality
and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal
ligation and puncture. Shock 13: 110-116.
70. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, et al. (1998) Essential role of
gamma interferon in survival of colon ascendens stent peritonitis, a novel murine
model of abdominal sepsis. Infect Immun 66: 2300-2309.
71. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D (2005) Acute
inflammatory response to endotoxin in mice and humans. Clin Diagn Lab
Immunol 12: 60-67.
72. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, et al. (2001) New strategies for
clinical trials in patients with sepsis and septic shock. Crit Care Med 29: 880-886.
73. Sharma J, Li Q, Mishra BB, Teale JM (2009) Lethal pulmonary infection with
Francisella novicida causes depletion of alphabeta T cells from lungs. Cell
Immunol 257: 1-4.
74. Mares CA, Sharma J, Li Q, Rangel EL, Morris EG, et al. (2011) Defect in
efferocytosis leads to alternative activation of macrophages in Francisella
infections. Immunol Cell Biol 89: 167-172.
75. Namas R, Zamora R, An G, Doyle J, Dick TE, et al. (2011) Sepsis: Something old,
something new, and a systems view. J Crit Care.
76. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J
Med 348: 138-150.
77. Sharma J, Li Q, Mishra BB, Pena C, Teale JM (2009) Lethal pulmonary infection
with Francisella novicida is associated with severe sepsis. J Leukoc Biol 86: 491504.
78. Sharma J, Li Q, Mishra BB, Georges MJ, Teale JM (2009) Vaccination with an
attenuated strain of Francisella novicida prevents T-cell depletion and protects
135

mice infected with the wild-type strain from severe sepsis. Infect Immun 77:
4314-4326.
79. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, et al. (2006) Lack of
in vitro and in vivo recognition of Francisella tularensis subspecies
lipopolysaccharide by Toll-like receptors. Infect Immun 74: 6730-6738.
80. Sharma J, Mares CA, Li Q, Morris EG, Teale JM (2011) Features of sepsis caused by
pulmonary infection with Francisella tularensis Type A strain. Microb Pathog 51:
39-47.
81. Wickstrum JR, Bokhari SM, Fischer JL, Pinson DM, Yeh HW, et al. (2009)
Francisella tularensis induces extensive caspase-3 activation and apoptotic cell
death in the tissues of infected mice. Infect Immun 77: 4827-4836.
82. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM (2008) Initial delay in the immune
response to Francisella tularensis is followed by hypercytokinemia characteristic
of severe sepsis and correlating with upregulation and release of damageassociated molecular patterns. Infect Immun 76: 3001-3010.
83. Mares CA, Sharma J, Ojeda SS, Li Q, Campos JA, et al. (2010) Attenuated response
of aged mice to respiratory Francisella novicida is characterized by reduced cell
death and absence of subsequent hypercytokinemia. PLoS One 5: e14088.
84. Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune
responses. Curr Opin Immunol 17: 359-365.
85. Cooper D, Iqbal AJ, Gittens BR, Cervone C, Perretti M (2012) The effect of galectins
on leukocyte trafficking in inflammation: sweet or sour? Ann N Y Acad Sci.
86. Li Y, Komai-Koma M, Gilchrist DS, Hsu DK, Liu FT, et al. (2008) Galectin-3 is a
negative regulator of lipopolysaccharide-mediated inflammation. J Immunol 181:
2781-2789.
87. Lopez E, del Pozo V, Miguel T, Sastre B, Seoane C, et al. (2006) Inhibition of
chronic airway inflammation and remodeling by galectin-3 gene therapy in a
murine model. J Immunol 176: 1943-1950.
88. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, et al. (2002) Galectins
and their ligands: amplifiers, silencers or tuners of the inflammatory response?
Trends Immunol 23: 313-320.
89. Gundra UM, Mishra BB, Wong K, Teale JM (2011) Increased disease severity of
parasite-infected TLR2-/- mice is correlated with decreased central nervous
system inflammation and reduced numbers of cells with alternatively activated
macrophage phenotypes in a murine model of neurocysticercosis. Infect Immun
79: 2586-2596.
90. Gonzalez-Juarrero M, Orme IM (2001) Characterization of murine lung dendritic
cells infected with Mycobacterium tuberculosis. Infect Immun 69: 1127-1133.
91. Mariathasan S, Weiss DS, Dixit VM, Monack DM (2005) Innate immunity against
Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202:
1043-1049.
92. Pani B, Ong HL, Liu X, Rauser K, Ambudkar IS, et al. (2008) Lipid rafts determine
clustering of STIM1 in endoplasmic reticulum-plasma membrane junctions and
regulation of store-operated Ca2+ entry (SOCE). J Biol Chem 283: 17333-17340.

136

93. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived
suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238244.
94. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infectedhost-cell repertoire and cellular response in the lung following inhalation of
Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76: 5843-5852.
95. Fry DE (2012) Sepsis, systemic inflammatory response, and multiple organ
dysfunction: the mystery continues. Am Surg 78: 1-8.
96. Wheeler DS, Lahni P, Odoms K, Jacobs BR, Carcillo JA, et al. (2007) Extracellular
heat shock protein 60 (Hsp60) levels in children with septic shock. Inflamm Res
56: 216-219.
97. Dagher SF, Wang JL, Patterson RJ (1995) Identification of galectin-3 as a factor in
pre-mRNA splicing. Proc Natl Acad Sci U S A 92: 1213-1217.
98. Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, et al.
(2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous
danger signals to promote inflammation. J Leukoc Biol 86: 655-662.
99. Berthelot F, Fattoum L, Casulli S, Gozlan J, Marechal V, et al. (2012) The effect of
HMGB1,
a
damage-associated
molecular
pattern
molecule,
on
polymorphonuclear neutrophil migration depends on its concentration. J Innate
Immun 4: 41-58.
100. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, et al. (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived
suppressor cells. J Immunol 181: 4666-4675.
101. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, et al. (2003) Blockade of
S100A8 and S100A9 suppresses neutrophil migration in response to
lipopolysaccharide. J Immunol 171: 2602-2609.
102. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A (2012) Neutrophil
function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
103. Schwartz JT, Barker JH, Kaufman J, Fayram DC, McCracken JM, et al. (2012)
Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay
constitutive apoptosis and prolong human neutrophil lifespan. J Immunol 188:
3351-3363.
104. Alves CM, Silva DA, Azzolini AE, Marzocchi-Machado CM, Carvalho JV, et al.
(2010) Galectin-3 plays a modulatory role in the life span and activation of
murine neutrophils during early Toxoplasma gondii infection. Immunobiology
215: 475-485.
105. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, et al. (2000) Targeted disruption of
the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J
Pathol 156: 1073-1083.
106. Mizgerd JP (2006) Lung infection--a public health priority. PLoS Med 3: e76.
107. Mizgerd JP (2008) Acute lower respiratory tract infection. N Engl J Med 358: 716727.
108. Fink MP (2001) Cytopathic hypoxia. Mitochondrial dysfunction as mechanism
contributing to organ dysfunction in sepsis. Crit Care Clin 17: 219-237.
109. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of
sepsis. Nat Med 9: 517-524.
137

110. John CM, Jarvis GA, Swanson KV, Leffler H, Cooper MD, et al. (2002) Galectin-3
binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is
selectively expressed by mucosal epithelial cells that are infected. Cell Microbiol
4: 649-662.
111. Kleshchenko YY, Moody TN, Furtak VA, Ochieng J, Lima MF, et al. (2004)
Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary
artery smooth muscle cells. Infect Immun 72: 6717-6721.
112. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG (2006) Galectin-3 induces
death of Candida species expressing specific beta-1,2-linked mannans. J Immunol
177: 4718-4726.
113. Pelletier I, Sato S (2002) Specific recognition and cleavage of galectin-3 by
Leishmania major through species-specific polygalactose epitope. J Biol Chem
277: 17663-17670.
114. Alleva LM, Budd AC, Clark IA (2008) Systemic release of high mobility group box
1 protein during severe murine influenza. J Immunol 181: 1454-1459.
115. Yang H, Ochani M, Li J, Qiang X, Tanovic M, et al. (2004) Reversing established
sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad
Sci U S A 101: 296-301.
116. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, et al. (2006) Anti-highmobility group box chromosomal protein 1 antibodies improve survival of rats
with sepsis. World J Surg 30: 1755-1762.
117. Hoogerwerf JJ, Van Der Windt GJ, Blok DC, Hoogendijk AJ, De Vos AF, et al.
(2012) Interleukin-1-receptor-associated kinase M deficient mice demonstrate an
improved host defense during gram-negative pneumonia. Mol Med.
118. Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae
carbapenemase-producing bacteria. Lancet Infect Dis 9: 228-236.
119. Eddens T, Kolls JK (2012) Host defenses against bacterial lower respiratory tract
infection. Curr Opin Immunol 24: 424-430.
120. Denk S, Perl M, Huber-Lang M (2012) Damage- and pathogen-associated molecular
patterns and alarmins: keys to sepsis? Eur Surg Res 48: 171-179.
121. Rabinovich GA, van Kooyk Y, Cobb BA (2012) Glycobiology of immune
responses. Ann N Y Acad Sci 1253: 1-15.
122. Arce I, Martinez-Munoz L, Roda-Navarro P, Fernandez-Ruiz E (2004) The human
C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor. Eur
J Immunol 34: 210-220.
123. Graham LM, Gupta V, Schafer G, Reid DM, Kimberg M, et al. (2012) The C-type
Lectin Receptor CLECSF8 (CLEC4D) Is Expressed by Myeloid Cells and
Triggers Cellular Activation through Syk Kinase. J Biol Chem 287: 25964-25974.
124. Mishra BB, Gundra UM, Teale JM (2011) STAT6(-)/(-) mice exhibit decreased cells
with alternatively activated macrophage phenotypes and enhanced disease
severity in murine neurocysticercosis. J Neuroimmunol 232: 26-34.
125. Torchinsky MB, Garaude J, Martin AP, Blander JM (2009) Innate immune
recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature
458: 78-82.

138

126. Batra S, Cai S, Balamayooran G, Jeyaseelan S (2012) Intrapulmonary administration
of leukotriene B(4) augments neutrophil accumulation and responses in the lung
to Klebsiella infection in CXCL1 knockout mice. J Immunol 188: 3458-3468.
127. Poe SL, Arora M, Oriss TB, Yarlagadda M, Isse K, et al. (2012) STAT1-regulated
lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with
relevance in resolution of bacterial pneumonia. Mucosal Immunol.
128. Kovach MA, Standiford TJ (2012) The function of neutrophils in sepsis. Curr Opin
Infect Dis 25: 321-327.
129. Harris HE, Andersson U, Pisetsky DS (2012) HMGB1: a multifunctional alarmin
driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8: 195-202.
130. Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, et al.
(2012) IL-33/ST2 axis in inflammation and immunopathology. Immunol Res 52:
89-99.
131. Broz P, Monack DM (2011) Molecular mechanisms of inflammasome activation
during microbial infections. Immunol Rev 243: 174-190.
132. Parmely MJ, Fischer JL, Pinson DM (2009) Programmed cell death and the
pathogenesis of tissue injury induced by type A Francisella tularensis. FEMS
Microbiol Lett 301: 1-11.
133. Brett ME, Respicio-Kingry LB, Yendell S, Ratard R, Hand J, et al. (2014) Outbreak
of Francisella novicida Bacteremia Among Inmates at a Louisiana Correctional
Facility. Clin Infect Dis 59: 826-833.
134. Fink MP (2014) HMGB1 as a drug target in staphylococcal pneumonia. Crit Care
18: 131.
135. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, et al. (2014) DAMP
molecule S100A9 acts as a molecular pattern to enhance inflammation during
influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS
Pathog 10: e1003848.
136. Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, et al.
(2002) Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated
apoptotic and non-apoptotic mechanisms. Cell Death Differ 9: 661-670.
137. Sato S, Nieminen J (2004) Seeing strangers or announcing "danger": galectin-3 in
two models of innate immunity. Glycoconj J 19: 583-591.
138. Balamayooran G, Batra S, Theivanthiran B, Cai S, Pacher P, et al. (2012)
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil
release to blood in gram-negative bacterial infection in MCP-1-/- mice. J
Immunol 189: 5849-5859.
139. Hall JD, Kurtz SL, Rigel NW, Gunn BM, Taft-Benz S, et al. (2009) The impact of
chemokine receptor CX3CR1 deficiency during respiratory infections with
Mycobacterium tuberculosis or Francisella tularensis. Clin Exp Immunol 156:
278-284.
140. Sangiuliano B, Perez NM, Moreira DF, Belizario JE (2014) Cell Death-Associated
Molecular-Pattern Molecules: Inflammatory Signaling and Control. Mediators
Inflamm 2014: 821043.
141. Liu FT, Rabinovich GA (2010) Galectins: regulators of acute and chronic
inflammation. Ann N Y Acad Sci 1183: 158-182.

139

142. Katoh S, Nobumoto A, Matsumoto N, Matsumoto K, Ehara N, et al. (2010)
Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic
pneumonia. Int Arch Allergy Immunol 153: 294-302.
143. Vega-Carrascal I, Reeves EP, Niki T, Arikawa T, McNally P, et al. (2011)
Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J
Immunol 186: 2897-2909.
144. Vega-Carrascal I, Bergin DA, McElvaney OJ, McCarthy C, Banville N, et al. (2014)
Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gramnegative bacterial killing: an effect abrogated within the cystic fibrosis lung. J
Immunol 192: 2418-2431.
145. Li X, Zhao YQ, Li CW, Yuan FL (2012) T cell immunoglobulin-3 as a new
therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets 16: 11451149.
146. Sakai K, Kawata E, Ashihara E, Nakagawa Y, Yamauchi A, et al. (2011) Galectin-9
ameliorates acute GVH disease through the induction of T-cell apoptosis. Eur J
Immunol 41: 67-75.
147. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3
ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6:
1245-1252.
148. Sada-Ovalle I, Chavez-Galan L, Torre-Bouscoulet L, Nava-Gamino L, Barrera L, et
al. (2012) The Tim3-galectin 9 pathway induces antibacterial activity in human
macrophages infected with Mycobacterium tuberculosis. J Immunol 189: 58965902.
149. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, et al. (2010) A crucial
role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in
hepatitis C infection. PLoS One 5: e9504.
150. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, et al. (2007)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on
innate immune cells. Science 318: 1141-1143.
151. Jayaraman P, Sada-Ovalle I, Beladi S, Anderson AC, Dardalhon V, et al. (2010)
Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 207:
2343-2354.
152. Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, et al. (2013)
IL-1beta promotes antimicrobial immunity in macrophages by regulating TNFR
signaling and caspase-3 activation. J Immunol 190: 4196-4204.
153. Steelman AJ, Li J (2014) Astrocyte galectin-9 potentiates microglial TNF secretion.
J Neuroinflammation 11: 144.
154. Gieseke F, Kruchen A, Tzaribachev N, Bentzien F, Dominici M, et al. (2013)
Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells
to suppress T-cell proliferation. Eur J Immunol 43: 2741-2749.
155. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, et al. (2011) Risk factors and
pathogenic significance of severe sepsis and septic shock in 2286 patients with
gram-negative bacteremia. J Infect 62: 26-33.
156. Achouiti A, Vogl T, Urban CF, Rohm M, Hommes TJ, et al. (2012) Myeloid-related
protein-14 contributes to protective immunity in gram-negative pneumonia
derived sepsis. PLoS Pathog 8: e1002987.
140

157. Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, et al. (2010)
Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17
production in a murine model of gram negative bacterial pneumonia. PLoS One 5:
e9896.
158. Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, et al. (2007) TLR9 is
required for protective innate immunity in Gram-negative bacterial pneumonia:
role of dendritic cells. J Immunol 179: 3937-3946.
159. Cai S, Batra S, Wakamatsu N, Pacher P, Jeyaseelan S (2012) NLRC4
inflammasome-mediated production of IL-1beta modulates mucosal immunity in
the lung against gram-negative bacterial infection. J Immunol 188: 5623-5635.
160. Kerscher B, Willment JA, Brown GD (2013) The Dectin-2 family of C-type lectinlike receptors: an update. Int Immunol 25: 271-277.
161. Kawata K, Illarionov P, Yang GX, Kenny TP, Zhang W, et al. (2012) Mincle and
human B cell function. J Autoimmun 39: 315-322.
162. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, et al. (1999) A novel
LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages.
J Immunol 163: 5039-5048.
163. Drummond RA, Saijo S, Iwakura Y, Brown GD (2011) The role of Syk/CARD9
coupled C-type lectins in antifungal immunity. Eur J Immunol 41: 276-281.
164. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, et al. (2013)
Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity
of mycobacteria through mincle/CARD9 signaling and the inflammasome. J
Immunol 190: 5722-5730.
165. Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, et al. (2009) Ctype lectin Mincle is an activating receptor for pathogenic fungus, Malassezia.
Proc Natl Acad Sci U S A 106: 1897-1902.
166. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004)
Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
167. Brinkmann V, Zychlinsky A (2012) Neutrophil extracellular traps: is immunity the
second function of chromatin? J Cell Biol 198: 773-783.
168. Yipp BG, Kubes P (2013) NETosis: how vital is it? Blood.
169. Lee WB, Kang JS, Yan JJ, Lee MS, Jeon BY, et al. (2012) Neutrophils Promote
Mycobacterial Trehalose Dimycolate-Induced Lung Inflammation via the Mincle
Pathway. PLoS Pathog 8: e1002614.
170. Vijayan D, Radford KJ, Beckhouse AG, Ashman RB, Wells CA (2012) Mincle
polarizes human monocyte and neutrophil responses to Candida albicans.
Immunol Cell Biol.
171. Matera G, Puccio R, Giancotti A, Quirino A, Pulicari MC, et al. (2013) Impact of
interleukin-10, soluble CD25 and interferon-gamma on the prognosis and early
diagnosis of bacteremic systemic inflammatory response syndrome: a prospective
observational study. Crit Care 17: R64.
172. Oh SJ, Kim JH, Chung DH (2013) NOD2-mediated suppression of CD55 on
neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog 9:
e1003351.
173. Sugitharini V, Prema A, Berla Thangam E (2013) Inflammatory mediators of
systemic inflammation in neonatal sepsis. Inflamm Res.
141

174. Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, et al. (2013) A novel
anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette
smoke-induced lung inflammation. PLoS One 8: e58258.
175. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P (2013) Current trends in
inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 93: 329342.
176. Ward PA (2012) New approaches to the study of sepsis. EMBO Mol Med 4: 12341243.
177. Behler F, Steinwede K, Balboa L, Ueberberg B, Maus R, et al. (2012) Role of
Mincle in Alveolar Macrophage-Dependent Innate Immunity against
Mycobacterial Infections in Mice. J Immunol 189: 3121-3129.
178. Donnelly LE, Barnes PJ (2012) Defective phagocytosis in airways disease. Chest
141: 1055-1062.
179. Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, et al. (2008) The
macrophage-inducible C-type lectin, mincle, is an essential component of the
innate immune response to Candida albicans. J Immunol 180: 7404-7413.
180. Strasser D, Neumann K, Bergmann H, Marakalala MJ, Guler R, et al. (2012) Syk
kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit
Card9 adaptor-mediated innate immunity. Immunity 36: 32-42.
181. Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, et al. (2002) Differential
activation of innate immune responses by adenovirus and adeno-associated virus
vectors. J Virol 76: 4580-4590.
182. Ofek I, Goldhar J, Keisari Y, Sharon N (1995) Nonopsonic phagocytosis of
microorganisms. Annu Rev Microbiol 49: 239-276.
183. Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, et al. (1996) Safety of
single-dose administration of an adeno-associated virus (AAV)-CFTR vector in
the primate lung. Gene Ther 3: 658-668.
184. Lee RT, Hsu TL, Huang SK, Hsieh SL, Wong CH, et al. (2011) Survey of immunerelated, mannose/fucose-binding C-type lectin receptors reveals widely divergent
sugar-binding specificities. Glycobiology 21: 512-520.
185. Angus DC, Wax RS (2001) Epidemiology of sepsis: an update. Crit Care Med 29:
S109-116.
186. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, et al. (2012)
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366: 20552064.
187. Jones BD, Faron M, Rasmussen JA, Fletcher JR (2014) Uncovering the components
of the Francisella tularensis virulence stealth strategy. Front Cell Infect Microbiol
4: 32.
188. Garcia-Vallejo JJ, van Kooyk Y (2009) Endogenous ligands for C-type lectin
receptors: the true regulators of immune homeostasis. Immunol Rev 230: 22-37.
189. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM (2009) Mannose-binding lectin and
innate immunity. Immunol Rev 230: 9-21.
190. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y (2004) Selfand nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol
22: 33-54.

142

191. Gordon S (2002) Pattern recognition receptors: doubling up for the innate immune
response. Cell 111: 927-930.
192. Kammerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TB, et al. (2003)
Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN
(CD209) in the decidua of early human pregnancy. Am J Pathol 162: 887-896.
193. Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition.
Nat Immunol 9: 495-502.
194. Ariel A, Maridonneau-Parini I, Rovere-Querini P, Levine JS, Muhl H (2012)
Macrophages in inflammation and its resolution. Front Immunol 3: 324.
195. Ariel A, Serhan CN (2012) New Lives Given by Cell Death: Macrophage
Differentiation Following Their Encounter with Apoptotic Leukocytes during the
Resolution of Inflammation. Front Immunol 3: 4.
196. Serhan CN, Chiang N (2013) Resolution phase lipid mediators of inflammation:
agonists of resolution. Curr Opin Pharmacol 13: 632-640.
197. McCubbrey AL, Curtis JL (2013) Efferocytosis and lung disease. Chest 143: 17501757.

143

